data_6f0y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6f0y _Structure_validation_residue.Date_analyzed 2017-12-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' A' ' 28' ' ' PHE . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.503 HD21 HG22 ' A' ' 69' ' ' VAL . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.617 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 132' ' ' VAL . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HA ' HD12 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CH2' HD12 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HB2' HD23 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.11 0.481 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG21 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.503 HG22 HD21 ' A' ' 7' ' ' LEU . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.412 HG21 ' HH ' ' A' ' 44' ' ' TYR . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.504 HD11 HD13 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.508 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.541 ' CD2' HG21 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.572 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.511 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 135' ' ' ILE . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.572 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.577 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.62 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.438 ' HB3' HG12 ' A' ' 62' ' ' VAL . 60.3 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.433 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 69' ' ' VAL . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.481 HG22 HG13 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 69' ' ' VAL . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 4' ' ' VAL . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' O ' HG11 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG21 HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.565 ' OD1' HD22 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.403 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 132' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.637 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 6' ' ' LEU . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HA ' HG12 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.464 HG23 HD13 ' A' ' 135' ' ' ILE . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 81' ' ' ALA . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.464 HD13 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.454 ' HA ' HG13 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.448 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.423 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.565 HD22 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.473 ' HB3' HG13 ' A' ' 62' ' ' VAL . 96.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' CD1' HD23 ' A' ' 97' ' ' LEU . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.496 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.495 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.487 HG22 HG22 ' A' ' 69' ' ' VAL . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB2' HG11 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.425 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.558 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.407 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 135' ' ' ILE . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 135' ' ' ILE . 27.7 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 81' ' ' ALA . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.433 HG12 ' CG1' ' A' ' 113' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.488 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.509 HG23 HG11 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.555 HG21 ' H ' ' B' ' 422' ' ' THR . 1.3 mt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 422' ' ' THR . . . . . 0.555 ' H ' HG21 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.427 ' HA ' ' HE2' ' B' ' 423' ' ' MET . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.452 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo . . . . . 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 HG11 ' CD1' ' A' ' 28' ' ' PHE . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.469 HD12 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 69' ' ' VAL . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 HG22 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 69' ' ' VAL . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.563 ' CD1' HG11 ' A' ' 4' ' ' VAL . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.631 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HH ' HG21 ' A' ' 93' ' ' THR . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.53 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.541 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 86' ' ' ALA . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.473 HG21 ' HH ' ' A' ' 44' ' ' TYR . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.62 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD12 HD12 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 6' ' ' LEU . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HG11 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.455 ' C ' HD21 ' A' ' 125' ' ' ASN . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.455 HD21 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.474 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.429 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.422 ' HA ' HG11 ' A' ' 113' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.519 ' HA ' ' HE3' ' B' ' 423' ' ' MET . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.53 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.488 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 28' ' ' PHE . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 HD11 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 29' ' ' GLU . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.585 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.478 HG21 HG12 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 69' ' ' VAL . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' N ' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.612 HD13 ' CE2' ' A' ' 101' ' ' TYR . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' HD23 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 pm0 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 37' ' ' ASP . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG23 HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.474 ' CG1' HG21 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 ' H ' HD21 ' A' ' 89' ' ' LEU . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.618 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CE2' HD13 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.54 HG11 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.401 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.507 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 135' ' ' ILE . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 41.9 t30 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.518 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.518 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.54 HG22 HG11 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.474 HG21 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 422' ' ' THR . . . . . 0.457 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.505 ' HB3' HG11 ' A' ' 62' ' ' VAL . 88.8 Cg_endo . . . . . 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 28' ' ' PHE . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.439 HD21 HG22 ' A' ' 69' ' ' VAL . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 24' ' ' PHE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.552 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 69' ' ' VAL . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.554 HD11 ' CE1' ' A' ' 101' ' ' TYR . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CH2' HD12 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' HD1' ' OE1' ' A' ' 55' ' ' GLN . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 93' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HD1' ' A' ' 44' ' ' TYR . 24.1 mp0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 132' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 55' ' ' GLN . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.644 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' A' ' 149' ' ' PHE . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 6' ' ' LEU . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.449 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.482 HD21 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.429 ' HB ' HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.492 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.516 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.499 ' HA ' ' HE3' ' B' ' 423' ' ' MET . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.436 HD21 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.545 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.497 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.467 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB2' HG21 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' HD21 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.587 ' CD2' HG21 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.488 HG13 HG23 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.475 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' HG12 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 135' ' ' ILE . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' CG2' ' HB1' ' A' ' 81' ' ' ALA . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.635 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.495 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.537 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.537 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.488 HG23 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.663 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 121.432 0.634 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.663 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.481 HD21 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo . . . . . 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 HD11 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 8.6 p30 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HZ2' ' HB3' ' A' ' 17' ' ' LYS . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.455 HG23 HG21 ' A' ' 69' ' ' VAL . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' HG11 ' A' ' 4' ' ' VAL . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 101' ' ' TYR . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.434 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CH2' HD11 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 94' ' ' VAL . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.287 0.089 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 62' ' ' VAL . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 132' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.725 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.529 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.628 ' CE1' HD11 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 HD13 ' A' ' 135' ' ' ILE . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.44 HH11 HG22 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 423' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' B' ' 423' ' ' MET . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.417 HD22 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.464 ' HB3' HG11 ' A' ' 62' ' ' VAL . 74.5 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 HD11 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 69' ' ' VAL . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.649 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.44 HG21 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.454 HG23 HG21 ' A' ' 69' ' ' VAL . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' N ' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' HG11 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.643 0.258 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.515 HG13 HD13 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.548 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.48 HG22 HD21 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.688 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.405 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 107' ' ' VAL . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.688 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.612 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.649 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.543 HG22 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.499 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.405 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t . . . . . 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.533 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.515 HD13 HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 28' ' ' PHE . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 69' ' ' VAL . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CD1' HD23 ' A' ' 97' ' ' LEU . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 69' ' ' VAL . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.458 ' CD1' HG12 ' A' ' 4' ' ' VAL . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HB2' HG22 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' B' ' 424' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.421 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.621 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.624 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.614 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 135' ' ' ILE . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.453 HD12 HG21 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.418 HG12 ' CG1' ' A' ' 113' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 421' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.597 0.713 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 422' ' ' THR . . . . . 0.546 ' H ' HG21 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 424' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 426' ' ' PRO . . . . . 0.504 ' HB3' HG12 ' A' ' 62' ' ' VAL . 72.6 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -112.06 86.71 2.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.086 0.47 . . . . 0.0 110.737 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 1.8 mpt? -83.8 65.48 8.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 68.5 -107.72 2.19 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.72 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p -80.73 115.66 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.55 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.503 HD21 HG22 ' A' ' 69' ' ' VAL . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.617 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 132' ' ' VAL . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HA ' HD12 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CH2' HD12 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' HB2' HD23 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.62 89.94 0.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m 69.83 -76.2 0.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.658 0.783 . . . . 0.0 112.051 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.0 t -142.61 -62.59 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.891 -0.506 . . . . 0.0 111.759 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.2 -0.65 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.876 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m 66.69 81.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.907 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.7 -10.04 56.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.237 0.542 . . . . 0.0 110.616 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 13.0 p-10 -100.84 1.88 40.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.551 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.8 m-70 67.37 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.012 0.82 . . . . 0.0 109.473 -171.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -48.2 131.01 16.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 110.963 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -130.28 122.51 28.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.437 -172.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG21 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.503 HG22 HD21 ' A' ' 7' ' ' LEU . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.483 ' OD1' HG21 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.412 HG21 ' HH ' ' A' ' 44' ' ' TYR . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.603 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.504 HD11 HD13 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.57 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.43 HH11 ' CD ' ' A' ' 156' ' ' GLU . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.508 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.541 ' CD2' HG21 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.572 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 135' ' ' ILE . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.572 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.577 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.423 ' HB ' ' OE1' ' A' ' 156' ' ' GLU . 60.1 t -107.67 120.24 58.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.55 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 59.0 m95 -97.29 137.49 36.22 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.641 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 35' ' ' LYS . 36.9 t0 64.52 -59.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.749 1.281 . . . . 0.0 113.342 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -88.85 31.77 0.84 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.534 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' OE2' HD22 ' A' ' 161' ' ' LEU . 52.5 tt0 -96.25 136.55 36.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.992 0.425 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -87.36 134.34 33.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.05 126.35 30.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.106 0.479 . . . . 0.0 111.204 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -148.21 -63.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.124 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -124.41 80.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.11 0.481 . . . . 0.0 110.189 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.44 HD22 ' OE2' ' A' ' 156' ' ' GLU . 83.2 mt -106.36 -1.65 23.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 78.1 m-85 -116.75 124.93 28.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.788 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 162' ' ' TYR . 42.9 Cg_exo -57.35 134.85 66.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.878 2.385 . . . . 0.0 112.172 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.62 106.97 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.754 2.303 . . . . 0.0 111.765 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 112.9 5.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.167 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.82 146.14 31.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.07 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.28 88.29 0.72 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.621 2.214 . . . . 0.0 112.505 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.6 162.75 50.95 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.625 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.251 1.18 0 CA-C-O 119.097 -0.478 . . . . 0.0 110.106 -177.686 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -131.91 157.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.071 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 177.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.62 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.438 ' HB3' HG12 ' A' ' 62' ' ' VAL . 60.3 Cg_endo -69.15 103.96 1.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -67.32 166.01 15.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.064 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -99.46 88.12 3.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 59.5 -100.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.712 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . 46.39 50.03 12.74 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.814 0.696 . . . . 0.0 112.243 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -76.99 144.11 38.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.548 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -136.9 140.36 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.885 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.6 1.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 110.846 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.94 68.01 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.174 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 79.16 -86.54 1.2 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.695 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.433 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t -94.03 135.72 35.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 69' ' ' VAL . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.481 HG22 HG13 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 69' ' ' VAL . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 4' ' ' VAL . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' O ' HG11 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 HG12 ' OG ' ' A' ' 50' ' ' SER . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 96.32 1.6 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m 71.55 -71.32 0.14 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.416 0.686 . . . . 0.0 112.323 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -142.16 -67.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -93.4 -2.07 55.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.872 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.539 ' OG ' HG12 ' A' ' 45' ' ' VAL . 15.1 m 68.27 101.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.469 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.38 -20.95 66.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.632 0.729 . . . . 0.0 109.854 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' HG3' ' A' ' 55' ' ' GLN . 7.4 p-10 -88.88 -2.4 58.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.15 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 69.85 28.69 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 111.919 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 69.43 131.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.753 0.821 . . . . 0.0 110.69 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 -120.74 116.17 24.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.433 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG21 HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.565 ' OD1' HD22 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.403 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 132' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.637 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 6' ' ' LEU . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' HA ' HG12 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.464 HG23 HD13 ' A' ' 135' ' ' ILE . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 81' ' ' ALA . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.464 HD13 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.454 ' HA ' HG13 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.448 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.67 131.48 65.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -76.69 -168.1 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.312 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.56 -14.21 1.97 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 111.723 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -77.84 -5.68 51.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.49 150.95 47.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.69 144.76 47.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -67.98 100.89 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 0.0 110.708 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -165.63 -71.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.571 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.31 51.47 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.26 15.12 3.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.611 0.72 . . . . 0.0 110.165 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -144.65 126.13 7.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.876 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.21 129.68 23.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.948 1.765 . . . . 0.0 111.609 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.19 86.9 1.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.532 2.154 . . . . 0.0 112.083 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.38 137.81 41.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.88 143.48 26.19 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.592 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.9 90.66 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.864 2.376 . . . . 0.0 112.307 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.31 75.12 1.14 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.537 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.103 -178.107 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -134.05 172.5 12.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.968 0.413 . . . . 0.0 110.328 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.423 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -87.43 156.52 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.565 HD22 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.473 ' HB3' HG13 ' A' ' 62' ' ' VAL . 96.2 Cg_endo -78.41 134.3 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 133.93 34.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -66.33 138.59 57.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -74.96 69.37 1.89 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.114 0.483 . . . . 0.0 112.289 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -86.66 8.13 23.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . 0.46 ' HZ1' ' HB3' ' B' ' 431' ' ' LYS . 5.2 mtpm? -68.87 105.29 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.715 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.64 142.25 35.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . 0.415 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.347 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 54.08 82.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 111.476 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 2.0 mpt? -81.63 65.59 6.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.26 -106.21 1.88 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -75.18 131.55 40.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' CD1' HD23 ' A' ' 97' ' ' LEU . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.496 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.487 HG22 HG22 ' A' ' 69' ' ' VAL . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' HB2' HG11 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG23 ' OD2' ' A' ' 54' ' ' ASP . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.3 104.2 1.54 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.2 m 72.04 -64.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.433 0.693 . . . . 0.0 111.837 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.8 t -166.56 -54.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.026 0.441 . . . . 0.0 110.162 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.81 -32.32 21.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.233 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 t 65.54 97.33 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.311 0.577 . . . . 0.0 111.018 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.2 mt -74.1 -7.89 54.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.703 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -88.6 -0.6 57.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.382 0.611 . . . . 0.0 109.484 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 66.03 31.55 8.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.069 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' OD2' HG23 ' A' ' 45' ' ' VAL . 53.1 m-20 68.48 141.62 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.587 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -121.1 115.52 23.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.14 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.425 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' SER . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.558 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.407 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 135' ' ' ILE . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.401 ' O ' HG13 ' A' ' 135' ' ' ILE . 27.7 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 81' ' ' ALA . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.433 HG12 ' CG1' ' A' ' 113' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.509 HG23 HG11 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.31 114.85 29.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.654 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 95.3 m95 -85.9 131.78 34.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 31.98 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.572 1.795 . . . . 0.0 114.585 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -151.04 13.85 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.513 -0.117 . . . . 0.0 110.74 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.464 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 37.5 tt0 -63.64 112.2 2.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -173.84 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.119 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 50.9 38.19 19.38 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.113 0.482 . . . . 0.0 111.436 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.33 -42.3 0.2 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.16 88.26 6.02 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.37 -32.29 71.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.985 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.46 110.34 28.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.476 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 138.98 71.75 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.145 2.564 . . . . 0.0 112.915 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.32 117.24 4.19 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.855 2.37 . . . . 0.0 111.71 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.14 128.28 34.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.019 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 1.9 mp0 -71.58 134.7 84.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 17.3 Cg_exo -66.41 81.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.033 2.488 . . . . 0.0 112.383 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.39 52.68 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.99 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.83 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 121.134 0.492 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -105.68 138.24 42.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.475 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.555 HG21 ' H ' ' B' ' 422' ' ' THR . 1.3 mt 55.67 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' THR . . . . . 0.555 ' H ' HG21 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.427 ' HA ' ' HE2' ' B' ' 423' ' ' MET . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.452 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo -76.72 80.06 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -54.54 135.64 45.8 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.614 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.56 136.8 58.16 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' B' ' 429' ' ' LYS . 1.0 OUTLIER -67.6 103.33 1.34 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.505 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.04 37.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.195 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.387 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 52.95 49.07 21.0 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.212 0.529 . . . . 0.0 111.169 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.953 179.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -137.53 66.64 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.38 67.43 4.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 75.05 -84.28 0.82 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 153' ' ' TRP . 35.8 m -94.22 126.23 39.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.566 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 HD12 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 69' ' ' VAL . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 HG22 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 69' ' ' VAL . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' CD1' HG11 ' A' ' 4' ' ' VAL . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.631 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' HH ' HG21 ' A' ' 93' ' ' THR . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' HD2' ' A' ' 49' ' ' ARG . . . -69.86 81.9 0.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m 65.2 -86.04 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.304 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 m -152.72 -20.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.859 0.361 . . . . 0.0 110.615 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -80.73 -26.57 37.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.083 178.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m 53.25 74.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.909 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.87 -15.78 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.612 0.72 . . . . 0.0 109.65 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.68 -10.64 47.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.926 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 66.95 29.52 8.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.712 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 104.57 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.797 0.686 . . . . 0.0 110.091 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 -113.06 118.16 34.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.53 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.541 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 86' ' ' ALA . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.473 HG21 ' HH ' ' A' ' 44' ' ' TYR . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.62 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD12 HD12 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 6' ' ' LEU . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HG11 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.455 ' C ' HD21 ' A' ' 125' ' ' ASN . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.455 HD21 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.474 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.429 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.422 ' HA ' HG11 ' A' ' 113' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.1 126.37 46.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.566 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 74.8 m95 -110.27 141.59 43.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.623 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.33 -62.47 0.17 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.559 1.162 . . . . 0.0 112.562 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -86.42 25.87 1.15 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.52 97.57 6.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.153 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -121.56 117.47 26.84 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 175.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.88 -174.99 5.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.076 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.11 -161.77 19.19 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 162' ' ' TYR . 28.8 t70 -88.4 51.41 2.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.489 0.661 . . . . 0.0 109.692 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt 66.23 -2.62 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.697 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 160' ' ' ASP . 85.6 m-85 -110.87 120.08 44.42 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HB3' ' OD1' ' A' ' 157' ' ' ASN . 22.7 Cg_endo -61.83 129.07 26.27 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.484 2.123 . . . . 0.0 113.074 -174.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -85.87 81.76 1.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.966 2.444 . . . . 0.0 110.428 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.05 111.48 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.841 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -83.04 147.38 54.02 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.776 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.26 74.7 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.606 2.204 . . . . 0.0 111.939 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.66 122.46 2.86 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.638 179.571 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -112.89 104.43 12.41 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.558 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 149.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.973 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.519 ' HA ' ' HE3' ' B' ' 423' ' ' MET . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.53 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.488 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo -78.9 65.53 8.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -63.57 146.82 52.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.879 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -62.81 165.91 6.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.658 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.76 18.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -168.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -84.61 39.43 0.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 111.183 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -91.95 -4.7 54.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -98.84 150.94 21.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.361 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.207 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.309 -0.317 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -107.15 78.83 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.006 0.432 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.35 56.14 3.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.393 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 77.9 -56.59 3.91 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.251 -0.5 . . . . 0.0 111.97 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -120.26 130.45 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.664 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 HD11 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 29' ' ' GLU . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.585 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.478 HG21 HG12 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.489 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 69' ' ' VAL . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' N ' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.612 HD13 ' CE2' ' A' ' 101' ' ' TYR . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' HD23 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.74 ' O ' ' HD3' ' A' ' 49' ' ' ARG . . . -69.83 86.47 0.29 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 m 47.93 -102.47 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.826 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 p -138.78 21.14 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.498 . . . . 0.0 110.609 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.74 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -112.74 -32.73 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.955 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m 44.96 56.78 5.1 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.556 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.14 -18.83 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 109.669 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.77 -5.55 57.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.701 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 66.6 16.1 10.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.225 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 67.55 147.97 0.05 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.707 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 pm0 -144.6 130.07 18.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 429' ' ' LYS . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG23 HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.474 ' CG1' HG21 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 ' H ' HD21 ' A' ' 89' ' ' LEU . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.618 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CE2' HD13 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.412 ' HD3' ' OE2' ' A' ' 156' ' ' GLU . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.54 HG11 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.401 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.507 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 135' ' ' ILE . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 41.9 t30 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.518 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.518 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.54 HG22 HG11 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.408 HD12 ' CZ2' ' A' ' 153' ' ' TRP . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.65 119.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.664 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 91.3 m95 -102.75 142.71 33.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.371 -176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.11 -66.06 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.563 1.164 . . . . 0.0 113.357 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -86.69 18.22 3.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.763 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' OE2' ' HD3' ' A' ' 104' ' ' ARG . 43.2 tt0 -65.83 133.9 51.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.39 133.0 42.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.329 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -89.99 157.45 17.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.74 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.29 117.85 10.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.947 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 67.39 48.08 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.347 0.659 . . . . 0.0 112.312 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.6 mt -88.09 -36.17 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.028 0.442 . . . . 0.0 110.07 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -115.01 92.73 32.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.034 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.61 130.91 39.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.593 2.195 . . . . 0.0 111.93 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.63 99.55 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.788 2.325 . . . . 0.0 111.733 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.94 144.52 56.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.956 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 166' ' ' GLN . 12.3 mm-40 -86.11 129.48 53.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.978 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 24.6 Cg_exo -62.86 102.87 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.678 2.252 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.25 92.38 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.056 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.86 -179.616 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 54.2 tp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . 61.88 -171.2 0.16 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.711 0.632 . . . . 0.0 111.288 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.474 HG21 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt 53.43 -139.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' THR . . . . . 0.457 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' B' ' 427' ' ' ARG . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.505 ' HB3' HG11 ' A' ' 62' ' ' VAL . 88.8 Cg_endo -79.6 -19.09 10.28 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' B' ' 425' ' ' LYS . 0.0 OUTLIER 52.56 -145.84 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -106.54 -171.33 1.87 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 15.3 ptmt -81.69 66.78 7.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.697 0.761 . . . . 0.0 111.564 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -126.91 62.49 1.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.297 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -86.24 94.56 9.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 110.555 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -87.92 54.7 3.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.649 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.296 179.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -162.12 126.95 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.3 tpp -122.49 56.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 78.38 -59.84 4.01 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -102.92 139.69 38.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 28' ' ' PHE . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.439 HD21 HG22 ' A' ' 69' ' ' VAL . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 24' ' ' PHE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.552 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 69' ' ' VAL . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.554 HD11 ' CE1' ' A' ' 101' ' ' TYR . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CH2' HD12 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG11 ' OG ' ' A' ' 50' ' ' SER . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 93' ' ' THR . . . -102.08 83.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m 66.79 -78.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.273 0.629 . . . . 0.0 111.223 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -153.31 -36.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.391 0.139 . . . . 0.0 110.989 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -67.52 -46.94 71.41 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.829 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.525 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 19.4 m 49.02 72.5 0.29 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.33 -67.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -97.7 23.48 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 50' ' ' SER . 79.7 m80 -130.0 58.88 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.561 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.685 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 4.0 p-10 -149.5 91.61 1.84 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.189 0.995 . . . . 0.0 110.067 167.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HD1' ' A' ' 44' ' ' TYR . 24.1 mp0 -129.0 120.93 26.9 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.86 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 132' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 55' ' ' GLN . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.644 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' A' ' 149' ' ' PHE . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 6' ' ' LEU . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.449 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.482 HD21 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.429 ' HB ' HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.492 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.1 111.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -69.03 -167.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.771 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -57.14 -8.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -78.08 -2.91 39.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.0 110.669 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.03 136.54 48.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -123.74 155.85 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -116.63 147.52 41.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 110.942 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.03 -74.79 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.146 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.22 78.98 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 0.0 111.331 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.8 mt -100.68 13.58 34.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.369 0.604 . . . . 0.0 109.567 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -128.89 115.3 19.05 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.636 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.06 154.8 72.58 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.82 2.346 . . . . 0.0 111.473 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.08 93.9 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.016 2.477 . . . . 0.0 112.677 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -87.44 112.65 22.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -86.3 114.69 58.81 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.374 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.3 77.47 2.06 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.756 2.304 . . . . 0.0 111.843 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.41 48.09 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.744 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.614 -179.505 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -111.27 128.57 55.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.516 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.6 144.23 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.499 ' HA ' ' HE3' ' B' ' 423' ' ' MET . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.436 HD21 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.545 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo -78.76 141.27 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.42 131.6 48.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.613 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.18 83.98 4.42 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.707 0.289 . . . . 0.0 110.345 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 34.19 66.73 0.25 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.567 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -106.09 31.38 5.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.241 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -102.57 -64.48 1.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.337 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 54.07 58.29 5.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.238 0.542 . . . . 0.0 110.848 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.347 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -105.17 78.13 1.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.979 0.419 . . . . 0.0 111.195 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.17 71.72 10.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.428 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.87 -95.82 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.952 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -82.73 132.05 35.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.647 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.497 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.467 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB2' HG21 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.467 HG23 ' OD1' ' A' ' 54' ' ' ASP . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.94 100.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m 74.41 -71.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.586 0.755 . . . . 0.0 111.88 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.8 p -151.36 -54.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -96.93 -23.22 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.119 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 68.17 112.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.362 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.89 -16.58 63.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' CG ' HE21 ' A' ' 55' ' ' GLN . 3.7 m-20 -83.95 -2.52 56.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.243 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 64.19 38.86 7.92 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.729 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' OD1' HG23 ' A' ' 45' ' ' VAL . 11.3 m-20 70.07 121.09 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.92 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 HE21 ' CG ' ' A' ' 52' ' ' ASP . 60.5 mt-30 -99.86 116.27 31.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' B' ' 427' ' ' ARG . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.505 HG23 HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' HD21 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.428 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.457 HG22 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.707 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.587 ' CD2' HG21 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.488 HG13 HG23 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.475 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' HG12 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 135' ' ' ILE . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' CG2' ' HB1' ' A' ' 81' ' ' ALA . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.635 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.495 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.537 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.537 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.488 HG23 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.35 119.26 52.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.647 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 47.2 m95 -93.9 142.3 27.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.405 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 77.7 m-20 65.83 -40.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.605 1.191 . . . . 0.0 113.712 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 153' ' ' TRP . 32.7 m-80 -119.8 40.16 3.47 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.439 -0.163 . . . . 0.0 111.369 -172.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.707 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 32.1 tt0 -63.25 116.61 5.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.35 125.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.085 0.865 . . . . 0.0 109.373 -170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -81.28 69.4 7.89 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.336 0.588 . . . . 0.0 110.792 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.83 -46.64 5.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.256 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.68 120.97 31.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.8 mt -116.05 34.61 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.995 0.426 . . . . 0.0 110.09 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -117.56 100.78 52.7 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.721 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.89 135.89 64.58 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.495 2.13 . . . . 0.0 111.435 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.84 117.29 3.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.81 2.34 . . . . 0.0 112.067 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -70.58 97.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -101.76 125.36 37.4 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.325 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.4 75.63 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.564 2.176 . . . . 0.0 111.427 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -70.58 -33.51 67.36 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.194 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.673 179.288 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.274 0.559 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -110.4 101.52 10.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.327 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.663 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER -107.16 148.37 11.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.911 -174.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.663 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.481 HD21 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo -65.25 141.08 67.35 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 13.1 ptm180 -92.26 172.36 8.46 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.522 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.55 160.99 15.14 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -81.04 45.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.743 0.782 . . . . 0.0 110.795 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -119.12 41.68 3.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.976 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -92.27 117.89 30.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.983 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 58.56 51.56 7.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.51 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.154 179.617 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 73.62 85.54 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.552 0.692 . . . . 0.0 111.826 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 43.8 mtt -87.13 68.38 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.956 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 69.07 -110.41 3.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.515 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -72.0 116.19 12.11 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD11 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 8.6 p30 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HZ2' ' HB3' ' A' ' 17' ' ' LYS . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 HG22 HG13 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.487 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.455 HG23 HG21 ' A' ' 69' ' ' VAL . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' HG11 ' A' ' 4' ' ' VAL . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 101' ' ' TYR . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.434 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CH2' HD11 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' HB3' ' A' ' 53' ' ' HIS . . . -115.37 112.96 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m 61.98 -89.7 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 O-C-N 124.273 0.631 . . . . 0.0 111.368 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -160.51 -32.98 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.096 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 50' ' ' SER . 0.0 OUTLIER -58.07 -42.36 85.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.555 0.217 . . . . 0.0 111.283 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.414 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 34.1 p 45.12 79.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.26 -52.88 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -100.85 13.4 35.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 48.8 m-70 -135.96 54.99 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.975 -172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 7.5 p-10 -149.05 93.97 2.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.973 0.892 . . . . 0.0 108.842 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -127.84 122.61 33.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.901 -170.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 62' ' ' VAL . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.466 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 132' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' ' HE1' ' A' ' 53' ' ' HIS . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.725 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.529 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.628 ' CE1' HD11 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG23 HD13 ' A' ' 135' ' ' ILE . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.44 HH11 HG22 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' CG1' ' HA ' ' A' ' 156' ' ' GLU . 24.1 t -106.31 136.32 41.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.53 -170.25 1.92 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.1 -12.76 54.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.262 0.553 . . . . 0.0 110.5 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -61.46 -49.05 78.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.004 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.425 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 37.5 tt0 54.97 64.82 1.68 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 159' ' ' GLY . 2.2 t-20 -153.07 -16.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.241 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.2 pm0 -80.69 28.59 0.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.585 0.707 . . . . 0.0 110.413 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 157' ' ' ASN . . . -95.88 -37.32 4.99 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.106 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.83 45.89 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.358 0.599 . . . . 0.0 110.604 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.0 mt -68.69 -37.67 79.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.067 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -121.09 86.26 42.26 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.449 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.72 129.77 28.94 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.312 2.008 . . . . 0.0 111.232 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.71 130.04 31.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.723 2.282 . . . . 0.0 112.441 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.62 147.97 37.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.762 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -111.31 134.71 21.06 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.129 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.25 60.09 3.9 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.559 2.173 . . . . 0.0 112.216 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -98.92 41.46 2.21 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.993 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.947 -179.443 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.643 0.259 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.36 112.75 20.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.927 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.35 147.02 19.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' B' ' 423' ' ' MET . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.417 HD22 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.464 ' HB3' HG11 ' A' ' 62' ' ' VAL . 74.5 Cg_endo -70.52 137.55 33.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.03 117.55 21.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -75.48 101.6 4.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -76.16 50.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.079 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -117.18 31.25 6.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.933 0.397 . . . . 0.0 111.239 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 162.23 37.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 56.34 36.84 28.17 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.603 0.565 . . . . 0.0 111.403 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.352 -178.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.43 78.87 1.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 110.978 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.75 58.17 4.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.958 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 81.35 -53.27 4.64 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -125.63 138.16 53.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.555 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 HD11 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 69' ' ' VAL . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.649 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.44 HG21 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.454 HG23 HG21 ' A' ' 69' ' ' VAL . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' N ' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' HG11 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG12 ' OG ' ' A' ' 50' ' ' SER . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.12 86.8 1.43 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.4 m 62.08 -89.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.981 0.512 . . . . 0.0 110.197 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.449 ' H ' ' HD2' ' A' ' 49' ' ' ARG . 22.8 m -145.59 19.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.081 0.467 . . . . 0.0 109.88 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -121.27 -60.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.044 -176.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.567 ' OG ' HG12 ' A' ' 45' ' ' VAL . 13.3 m 67.74 100.2 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.817 0.698 . . . . 0.0 111.105 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.5 -34.58 72.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -84.69 12.27 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.693 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 63.05 41.27 8.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 69.72 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 -108.43 115.94 31.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.55 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.515 HG13 HD13 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.548 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG22 HD21 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.638 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.558 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.688 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.405 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 107' ' ' VAL . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.688 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.612 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.649 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.543 HG22 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.499 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.405 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t -94.92 112.3 27.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.555 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 60.4 m95 -75.25 -172.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.578 176.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.444 ' OD2' ' HD3' ' A' ' 35' ' ' LYS . 19.0 t70 -75.4 73.33 2.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.692 0.758 . . . . 0.0 110.019 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -158.88 -118.67 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.169 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -165.79 59.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.069 0.461 . . . . 0.0 109.844 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -174.07 158.4 3.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.748 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.443 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 5.7 pt-20 -119.28 52.46 1.08 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.589 0.709 . . . . 0.0 109.96 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.59 49.33 1.11 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.227 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.6 38.89 29.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 111.475 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.408 HD11 ' HG3' ' A' ' 158' ' ' GLU . 58.1 mt -105.34 1.3 27.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.422 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 158' ' ' GLU . 2.1 m-85 -120.53 89.64 44.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.763 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.76 133.15 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.21 1.94 . . . . 0.0 111.888 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.22 75.92 2.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.667 2.245 . . . . 0.0 111.94 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.62 144.2 56.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.12 115.98 65.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.211 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.07 143.39 84.38 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.723 2.282 . . . . 0.0 111.834 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.64 -117.23 4.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.795 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.692 -179.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.5 mt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.449 0.642 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -146.33 120.12 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.491 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.433 ' HA ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -77.29 159.64 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.515 HD13 HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo -82.34 83.54 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -63.21 131.99 50.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.735 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -84.01 92.34 7.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.206 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.05 -26.09 63.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . 0.49 ' HB3' ' OG ' ' A' ' 59' ' ' SER . . . -145.8 81.99 1.62 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.849 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -84.74 162.55 19.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.447 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.41 126.98 31.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.409 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.258 -178.359 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.97 104.38 12.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -94.29 63.74 3.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.255 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 74.31 -74.52 1.24 Allowed Glycine 0 N--CA 1.453 -0.197 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -117.61 125.44 50.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.618 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 69' ' ' VAL . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CD1' HD23 ' A' ' 97' ' ' LEU . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 69' ' ' VAL . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.458 ' CD1' HG12 ' A' ' 4' ' ' VAL . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HB2' HG22 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.24 127.45 7.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.8 m 69.69 -74.43 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 t -158.7 -50.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 110.066 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.27 -100.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.431 ' HG ' ' CG ' ' A' ' 54' ' ' ASP . 36.7 t 171.78 128.05 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 123.555 0.534 . . . . 0.0 111.537 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.8 mt -104.27 -67.43 0.9 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -117.23 23.69 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.812 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 54.1 m-70 -133.25 66.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -169.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 19.2 p-10 -149.4 76.94 1.33 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.518 1.151 . . . . 0.0 109.821 167.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.82 116.99 28.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.595 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' B' ' 426' ' ' PRO . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' B' ' 424' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.621 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.624 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.614 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.614 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 135' ' ' ILE . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.453 HD12 HG21 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.418 HG12 ' CG1' ' A' ' 113' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.45 123.47 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.618 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 90.0 m95 -100.39 134.46 43.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -169.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 21.7 t70 57.86 -57.99 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.345 1.653 . . . . 0.0 113.595 175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.21 46.49 1.07 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 122.942 0.497 . . . . 0.0 110.944 -174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.05 96.6 5.15 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.525 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 33.7 t30 70.22 134.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 122.127 0.965 . . . . 0.0 112.602 171.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.87 69.48 0.71 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.3 55.34 5.03 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.647 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.17 73.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.093 0.473 . . . . 0.0 110.034 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.65 10.08 1.93 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.941 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -118.43 93.34 45.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 51.7 Cg_exo -55.97 135.88 71.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.092 2.528 . . . . 0.0 112.455 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 59.9 Cg_endo -88.43 85.49 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.659 2.24 . . . . 0.0 111.801 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.72 106.72 11.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.265 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -76.56 119.54 77.8 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.58 65.59 8.62 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.701 2.267 . . . . 0.0 112.391 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.99 46.8 3.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.115 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.165 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 65.0 tp . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.784 0.326 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' ALA . . . . . 0.41 ' C ' HG13 ' B' ' 421' ' ' ILE . . . -87.64 134.51 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.33 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.9 OUTLIER 57.0 -179.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.936 -176.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' THR . . . . . 0.546 ' H ' HG21 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' PRO . . . . . 0.504 ' HB3' HG12 ' A' ' 62' ' ' VAL . 72.6 Cg_endo -71.95 104.61 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -63.75 135.0 56.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -70.61 172.21 9.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -76.05 53.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.582 0.706 . . . . 0.0 112.146 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.54 31.72 5.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -78.7 -26.34 44.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.828 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -81.5 62.53 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.641 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.766 -179.179 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 28' ' ' PHE . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD13 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CD1' HD22 ' A' ' 97' ' ' LEU . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.627 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.816 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.484 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' HA ' HD13 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 62' ' ' VAL . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CH2' HD13 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB2' HD21 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 5.7 pt20 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.11 0.481 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' B' ' 426' ' ' PRO . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.568 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' A' ' 34' ' ' LEU . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.621 ' CD2' HG23 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.425 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.503 HG11 ' HB1' ' A' ' 81' ' ' ALA . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.582 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.586 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 423' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.489 ' HB2' HD12 ' A' ' 60' ' ' ILE . 60.3 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 109' ' ' VAL . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 136' ' ' VAL . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' ASP . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.674 HD11 HD11 ' A' ' 97' ' ' LEU . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HD13 ' A' ' 7' ' ' LEU . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' A' ' 7' ' ' LEU . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' O ' HG13 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.628 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.739 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.675 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' OD1' HD23 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD11 HD11 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 151' ' ' ILE . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.943 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.601 HG11 ' HB1' ' A' ' 81' ' ' ALA . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 19' ' ' THR . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.58 ' HA ' HG12 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.452 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.943 HG22 HG13 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.579 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.499 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 96.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 28' ' ' PHE . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 109' ' ' VAL . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 24' ' ' PHE . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.498 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.481 HG23 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 97' ' ' LEU . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.543 ' HA ' HD13 ' A' ' 7' ' ' LEU . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.658 ' HB2' HG23 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 94' ' ' VAL . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.489 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 62' ' ' VAL . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 424' ' ' LEU . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.498 ' OG1' HG23 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.564 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' CD1' HG23 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.503 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.498 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 136' ' ' VAL . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 89' ' ' LEU . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 135' ' ' ILE . 95.6 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 11' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.568 HG22 ' H ' ' B' ' 422' ' ' THR . 1.3 mt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.568 ' H ' HG22 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 423' ' ' MET . . . . . 0.497 ' HE1' ' O ' ' A' ' 71' ' ' LYS . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.475 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo . . . . . 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' CD1' ' A' ' 28' ' ' PHE . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.491 HD13 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 109' ' ' VAL . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.641 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.587 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' A' ' 7' ' ' LEU . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD23 HG22 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' HB3' ' HG3' ' A' ' 55' ' ' GLN . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.839 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' B' ' 422' ' ' THR . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.536 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 55' ' ' GLN . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 116' ' ' GLU . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.625 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' SER . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' SER . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HD2' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.561 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.456 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.548 HD12 HG13 ' A' ' 11' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 140' ' ' LEU . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 148' ' ' ARG . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.422 HG21 ' HD2' ' A' ' 66' ' ' PRO . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 423' ' ' MET . . . . . 0.412 ' CE ' ' HB3' ' A' ' 71' ' ' LYS . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.536 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.515 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 28' ' ' PHE . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.49 HD13 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 109' ' ' VAL . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.733 HD11 HD11 ' A' ' 97' ' ' LEU . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.618 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.638 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.749 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' OE1' ' A' ' 56' ' ' GLU . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB2' HD21 ' A' ' 57' ' ' LEU . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.659 ' N ' HE21 ' A' ' 55' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 37' ' ' ASP . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.626 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 26' ' ' ILE . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' CE2' HD12 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 151' ' ' ILE . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.408 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.464 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.482 ' CG2' HD21 ' A' ' 89' ' ' LEU . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 2.9 t-20 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.577 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 106' ' ' PHE . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.518 HG23 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.481 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 423' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.527 ' HB3' HG13 ' A' ' 62' ' ' VAL . 88.8 Cg_endo . . . . . 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 38' ' ' LEU . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.543 HD13 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG13 HD12 ' A' ' 139' ' ' ILE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 136' ' ' VAL . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 7' ' ' LEU . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.699 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 61' ' ' LEU . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 57' ' ' LEU . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.639 ' HD1' ' NE2' ' A' ' 55' ' ' GLN . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.639 ' NE2' ' HD1' ' A' ' 44' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 42' ' ' LEU . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.461 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 57' ' ' LEU . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.476 HG21 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 106' ' ' PHE . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.981 HG13 HG22 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG23 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.981 HG22 HG13 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.587 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 109' ' ' VAL . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 97' ' ' LEU . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' HD13 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 61' ' ' LEU . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG23 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' OH ' HG21 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 43' ' ' THR . 60.5 mt-30 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.45 HG21 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.615 ' CD2' HG23 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.416 ' HG3' ' HG ' ' A' ' 122' ' ' LEU . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 121' ' ' GLU . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG11 ' CB ' ' A' ' 81' ' ' ALA . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.506 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.567 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 106' ' ' PHE . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.678 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 121.432 0.634 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 423' ' ' MET . . . . . 0.678 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo . . . . . 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.575 HD13 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD22 ' A' ' 97' ' ' LEU . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 1.9 p-10 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.418 HG23 HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 67' ' ' VAL . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.818 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.701 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.575 ' CH2' HD13 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 94' ' ' VAL . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.287 0.089 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 37' ' ' ASP . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.661 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.818 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' CYS . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.732 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE1' HD12 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' HD13 ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.919 HG13 HG22 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.431 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 81' ' ' ALA . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.492 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.547 HH11 HG21 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.919 HG22 HG13 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 66' ' ' PRO . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.479 ' HB3' HG13 ' A' ' 62' ' ' VAL . 74.5 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 HD13 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 29' ' ' GLU . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 109' ' ' VAL . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 139' ' ' ILE . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' SER . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 97' ' ' LEU . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.404 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB2' HG23 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' HD13 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' OH ' HG21 ' A' ' 93' ' ' THR . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.643 0.258 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.573 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.73 HG12 HD12 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 84' ' ' ILE . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.699 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.428 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB2' HD13 ' A' ' 151' ' ' ILE . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.633 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.629 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.436 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.56 HG23 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.629 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 11' ' ' VAL . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.428 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t . . . . . 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.413 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.533 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 70' ' ' ASN . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.73 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 425' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 28' ' ' PHE . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.599 HD13 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.549 HD11 HG21 ' A' ' 109' ' ' VAL . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 139' ' ' ILE . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.404 HG23 HG11 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD23 HG22 ' A' ' 65' ' ' VAL . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 38' ' ' LEU . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.494 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 422' ' ' THR . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 80' ' ' SER . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.727 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.619 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.667 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 11' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.727 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 108' ' ' ARG . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 421' ' ' ILE . . . . . 0.585 HG22 ' H ' ' B' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.597 0.713 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 422' ' ' THR . . . . . 0.585 ' H ' HG22 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 424' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 426' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 62' ' ' VAL . 72.6 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -112.06 86.71 2.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.086 0.47 . . . . 0.0 110.737 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . 0.475 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 1.8 mpt? -83.8 65.48 8.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 68.5 -107.72 2.19 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.72 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p -80.73 115.66 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.557 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD13 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CD1' HD22 ' A' ' 97' ' ' LEU . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.627 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.816 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.484 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' HA ' HD13 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.475 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 62' ' ' VAL . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CH2' HD13 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB2' HD21 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.62 89.94 0.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m 69.83 -76.2 0.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.658 0.783 . . . . 0.0 112.051 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.0 t -142.61 -62.59 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.891 -0.506 . . . . 0.0 111.759 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.2 -0.65 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.876 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m 66.69 81.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.907 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.7 -10.04 56.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.237 0.542 . . . . 0.0 110.616 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 13.0 p-10 -100.84 1.88 40.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.551 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.8 m-70 67.37 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.012 0.82 . . . . 0.0 109.473 -171.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -48.2 131.01 16.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 110.963 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 5.7 pt20 -130.28 122.51 28.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.437 -172.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' B' ' 426' ' ' PRO . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.568 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' A' ' 34' ' ' LEU . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 156' ' ' GLU . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.621 ' CD2' HG23 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.425 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.503 HG11 ' HB1' ' A' ' 81' ' ' ALA . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.582 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.586 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' OE1' ' A' ' 156' ' ' GLU . 60.1 t -107.67 120.24 58.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.557 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 59.0 m95 -97.29 137.49 36.22 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.641 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 35' ' ' LYS . 36.9 t0 64.52 -59.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.749 1.281 . . . . 0.0 113.342 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -88.85 31.77 0.84 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.534 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.47 ' OE2' HD21 ' A' ' 161' ' ' LEU . 52.5 tt0 -96.25 136.55 36.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.992 0.425 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -87.36 134.34 33.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.05 126.35 30.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.106 0.479 . . . . 0.0 111.204 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -148.21 -63.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.124 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -124.41 80.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.11 0.481 . . . . 0.0 110.189 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.47 HD21 ' OE2' ' A' ' 156' ' ' GLU . 83.2 mt -106.36 -1.65 23.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 78.1 m-85 -116.75 124.93 28.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.788 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 162' ' ' TYR . 42.9 Cg_exo -57.35 134.85 66.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.878 2.385 . . . . 0.0 112.172 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.62 106.97 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.754 2.303 . . . . 0.0 111.765 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 112.9 5.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.167 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.82 146.14 31.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.07 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.28 88.29 0.72 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.621 2.214 . . . . 0.0 112.505 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.6 162.75 50.95 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.625 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.251 1.18 0 CA-C-O 119.097 -0.478 . . . . 0.0 110.106 -177.686 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -131.91 157.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.071 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 177.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.489 ' HB2' HD12 ' A' ' 60' ' ' ILE . 60.3 Cg_endo -69.15 103.96 1.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -67.32 166.01 15.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.064 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -99.46 88.12 3.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 59.5 -100.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.712 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . 46.39 50.03 12.74 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.814 0.696 . . . . 0.0 112.243 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -76.99 144.11 38.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.548 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -136.9 140.36 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 433' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.885 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.6 1.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 110.846 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.94 68.01 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.174 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 79.16 -86.54 1.2 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.695 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t -94.03 135.72 35.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 109' ' ' VAL . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 136' ' ' VAL . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' ASP . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.674 HD11 HD11 ' A' ' 97' ' ' LEU . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HD13 ' A' ' 7' ' ' LEU . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' A' ' 7' ' ' LEU . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' O ' HG13 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.628 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.739 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG13 ' OG ' ' A' ' 50' ' ' SER . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 96.32 1.6 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m 71.55 -71.32 0.14 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.416 0.686 . . . . 0.0 112.323 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -142.16 -67.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -93.4 -2.07 55.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.872 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.536 ' OG ' HG13 ' A' ' 45' ' ' VAL . 15.1 m 68.27 101.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.469 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.38 -20.95 66.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.632 0.729 . . . . 0.0 109.854 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' HG3' ' A' ' 55' ' ' GLN . 7.4 p-10 -88.88 -2.4 58.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.15 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 69.85 28.69 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 111.919 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 11.1 m-20 69.43 131.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.753 0.821 . . . . 0.0 110.69 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 -120.74 116.17 24.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.433 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.675 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' OD1' HD23 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD11 HD11 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 151' ' ' ILE . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.943 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.601 HG11 ' HB1' ' A' ' 81' ' ' ALA . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 19' ' ' THR . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.58 ' HA ' HG12 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.452 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.943 HG22 HG13 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.67 131.48 65.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -76.69 -168.1 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.312 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.56 -14.21 1.97 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 111.723 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -77.84 -5.68 51.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.49 150.95 47.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.69 144.76 47.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -67.98 100.89 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 0.0 110.708 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -165.63 -71.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.571 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.31 51.47 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.26 15.12 3.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.611 0.72 . . . . 0.0 110.165 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -144.65 126.13 7.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.876 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.21 129.68 23.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.948 1.765 . . . . 0.0 111.609 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.19 86.9 1.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.532 2.154 . . . . 0.0 112.083 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.38 137.81 41.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.88 143.48 26.19 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.592 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.9 90.66 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.864 2.376 . . . . 0.0 112.307 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.31 75.12 1.14 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.537 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.103 -178.107 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -134.05 172.5 12.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.968 0.413 . . . . 0.0 110.328 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -87.43 156.52 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.579 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.499 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 96.2 Cg_endo -78.41 134.3 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 133.93 34.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -66.33 138.59 57.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -74.96 69.37 1.89 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.114 0.483 . . . . 0.0 112.289 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -86.66 8.13 23.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -68.87 105.29 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.715 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.64 142.25 35.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 433' ' ' LEU . . . . . 0.42 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.347 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 54.08 82.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 111.476 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 2.0 mpt? -81.63 65.59 6.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.26 -106.21 1.88 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -75.18 131.55 40.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 109' ' ' VAL . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 24' ' ' PHE . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.498 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.481 HG23 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 97' ' ' LEU . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.543 ' HA ' HD13 ' A' ' 7' ' ' LEU . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.658 ' HB2' HG23 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' A' ' 54' ' ' ASP . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.3 104.2 1.54 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.2 m 72.04 -64.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.433 0.693 . . . . 0.0 111.837 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.8 t -166.56 -54.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.026 0.441 . . . . 0.0 110.162 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.81 -32.32 21.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.233 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 t 65.54 97.33 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.311 0.577 . . . . 0.0 111.018 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.2 mt -74.1 -7.89 54.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.703 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -88.6 -0.6 57.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.382 0.611 . . . . 0.0 109.484 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 66.03 31.55 8.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.069 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 45' ' ' VAL . 53.1 m-20 68.48 141.62 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.587 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -121.1 115.52 23.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.14 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.489 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 62' ' ' VAL . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 424' ' ' LEU . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 47' ' ' SER . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 ' OG1' HG23 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.564 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.48 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' CD1' HG23 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.503 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.498 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 136' ' ' VAL . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 89' ' ' LEU . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 135' ' ' ILE . 95.6 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 11' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.31 114.85 29.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.665 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 95.3 m95 -85.9 131.78 34.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 31.98 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.572 1.795 . . . . 0.0 114.585 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -151.04 13.85 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.513 -0.117 . . . . 0.0 110.74 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 37.5 tt0 -63.64 112.2 2.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -173.84 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.119 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 50.9 38.19 19.38 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.113 0.482 . . . . 0.0 111.436 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.33 -42.3 0.2 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.16 88.26 6.02 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.37 -32.29 71.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.985 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.46 110.34 28.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.476 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 138.98 71.75 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.145 2.564 . . . . 0.0 112.915 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.32 117.24 4.19 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.855 2.37 . . . . 0.0 111.71 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.14 128.28 34.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.019 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 26.3 mp0 -71.58 134.7 84.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 17.3 Cg_exo -66.41 81.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.033 2.488 . . . . 0.0 112.383 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.39 52.68 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.99 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.83 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 121.134 0.492 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -105.68 138.24 42.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.475 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.568 HG22 ' H ' ' B' ' 422' ' ' THR . 1.3 mt 55.67 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.568 ' H ' HG22 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 423' ' ' MET . . . . . 0.497 ' HE1' ' O ' ' A' ' 71' ' ' LYS . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.475 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo -76.72 80.06 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -54.54 135.64 45.8 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.614 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.56 136.8 58.16 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' B' ' 429' ' ' LYS . 1.0 OUTLIER -67.6 103.33 1.34 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.505 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.04 37.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.195 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.387 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 52.95 49.07 21.0 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.212 0.529 . . . . 0.0 111.169 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.953 179.525 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -137.53 66.64 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.38 67.43 4.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 75.05 -84.28 0.82 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 153' ' ' TRP . 35.8 m -94.22 126.23 39.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 153' ' ' TRP . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' CD1' ' A' ' 28' ' ' PHE . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.491 HD13 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 109' ' ' VAL . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.641 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.587 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' A' ' 7' ' ' LEU . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD23 HG22 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' HB3' ' HG3' ' A' ' 55' ' ' GLN . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 49' ' ' ARG . . . -69.86 81.9 0.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m 65.2 -86.04 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.304 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 m -152.72 -20.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.859 0.361 . . . . 0.0 110.615 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -80.73 -26.57 37.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.083 178.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m 53.25 74.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.909 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.87 -15.78 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.612 0.72 . . . . 0.0 109.65 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.68 -10.64 47.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.926 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 66.95 29.52 8.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.712 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 104.57 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.797 0.686 . . . . 0.0 110.091 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 -113.06 118.16 34.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.839 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' B' ' 422' ' ' THR . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.536 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 55' ' ' GLN . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 116' ' ' GLU . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.625 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.41 ' HD2' ' OE2' ' A' ' 156' ' ' GLU . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' SER . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HD2' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.561 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.456 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.548 HD12 HG13 ' A' ' 11' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 140' ' ' LEU . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 148' ' ' ARG . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.1 126.37 46.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 74.8 m95 -110.27 141.59 43.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.623 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.33 -62.47 0.17 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.559 1.162 . . . . 0.0 112.562 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -86.42 25.87 1.15 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 104' ' ' ARG . 38.6 tt0 -79.52 97.57 6.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.153 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -121.56 117.47 26.84 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 175.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -86.88 -174.99 5.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.076 -174.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.11 -161.77 19.19 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 162' ' ' TYR . 28.8 t70 -88.4 51.41 2.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.489 0.661 . . . . 0.0 109.692 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt 66.23 -2.62 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.697 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 160' ' ' ASP . 85.6 m-85 -110.87 120.08 44.42 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HB3' ' OD1' ' A' ' 157' ' ' ASN . 22.7 Cg_endo -61.83 129.07 26.27 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.484 2.123 . . . . 0.0 113.074 -174.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -85.87 81.76 1.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.966 2.444 . . . . 0.0 110.428 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.05 111.48 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.841 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -83.04 147.38 54.02 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.776 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.26 74.7 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.606 2.204 . . . . 0.0 111.939 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.66 122.46 2.86 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.638 179.571 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -112.89 104.43 12.41 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.558 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 149.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.973 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.422 HG21 ' HD2' ' A' ' 66' ' ' PRO . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 423' ' ' MET . . . . . 0.412 ' CE ' ' HB3' ' A' ' 71' ' ' LYS . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.536 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.515 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo -78.9 65.53 8.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -63.57 146.82 52.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.879 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -62.81 165.91 6.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.658 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.76 18.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -168.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -84.61 39.43 0.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 111.183 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -91.95 -4.7 54.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -98.84 150.94 21.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.361 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.207 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.309 -0.317 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -107.15 78.83 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.006 0.432 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.35 56.14 3.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.393 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 77.9 -56.59 3.91 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.251 -0.5 . . . . 0.0 111.97 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -120.26 130.45 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 HD13 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 109' ' ' VAL . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.733 HD11 HD11 ' A' ' 97' ' ' LEU . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.618 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.638 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.749 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' OE1' ' A' ' 56' ' ' GLU . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB2' HD21 ' A' ' 57' ' ' LEU . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' O ' ' HD3' ' A' ' 49' ' ' ARG . . . -69.83 86.47 0.29 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 m 47.93 -102.47 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.826 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 p -138.78 21.14 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.498 . . . . 0.0 110.609 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -112.74 -32.73 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.955 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m 44.96 56.78 5.1 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.556 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.14 -18.83 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 109.669 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.77 -5.55 57.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.701 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 66.6 16.1 10.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.225 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 67.55 147.97 0.05 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.707 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 pm0 -144.6 130.07 18.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 37' ' ' ASP . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.626 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 26' ' ' ILE . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' CE2' HD12 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 151' ' ' ILE . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.408 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.464 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.482 ' CG2' HD21 ' A' ' 89' ' ' LEU . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 2.9 t-20 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.577 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 106' ' ' PHE . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.65 119.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.673 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 91.3 m95 -102.75 142.71 33.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.371 -176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.11 -66.06 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.563 1.164 . . . . 0.0 113.357 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -86.69 18.22 3.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.763 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 104' ' ' ARG . 43.2 tt0 -65.83 133.9 51.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.39 133.0 42.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.329 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -89.99 157.45 17.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.74 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.29 117.85 10.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.947 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 67.39 48.08 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.347 0.659 . . . . 0.0 112.312 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.6 mt -88.09 -36.17 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.028 0.442 . . . . 0.0 110.07 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -115.01 92.73 32.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.034 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.61 130.91 39.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.593 2.195 . . . . 0.0 111.93 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.63 99.55 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.788 2.325 . . . . 0.0 111.733 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.94 144.52 56.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.956 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 12.3 mm-40 -86.11 129.48 53.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.978 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 24.6 Cg_exo -62.86 102.87 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.678 2.252 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.25 92.38 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.056 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.86 -179.616 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 54.2 tp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . 61.88 -171.2 0.16 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.711 0.632 . . . . 0.0 111.288 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.518 HG23 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt 53.43 -139.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.481 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 423' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 425' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' B' ' 427' ' ' ARG . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.527 ' HB3' HG13 ' A' ' 62' ' ' VAL . 88.8 Cg_endo -79.6 -19.09 10.28 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' B' ' 425' ' ' LYS . 0.0 OUTLIER 52.56 -145.84 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -106.54 -171.33 1.87 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 15.3 ptmt -81.69 66.78 7.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.697 0.761 . . . . 0.0 111.564 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -126.91 62.49 1.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.297 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -86.24 94.56 9.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 110.555 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -87.92 54.7 3.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.649 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.296 179.523 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -162.12 126.95 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.3 tpp -122.49 56.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 78.38 -59.84 4.01 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . 3.5 p -102.92 139.69 38.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 38' ' ' LEU . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD13 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG13 HD12 ' A' ' 139' ' ' ILE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 136' ' ' VAL . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 7' ' ' LEU . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.699 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 61' ' ' LEU . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 57' ' ' LEU . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG13 ' OG ' ' A' ' 50' ' ' SER . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' THR . . . -102.08 83.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m 66.79 -78.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.273 0.629 . . . . 0.0 111.223 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -153.31 -36.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.391 0.139 . . . . 0.0 110.989 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.512 ' HG2' ' N ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -67.52 -46.94 71.41 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.829 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.512 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 19.4 m 49.02 72.5 0.29 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.33 -67.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -97.7 23.48 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 50' ' ' SER . 79.7 m80 -130.0 58.88 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.561 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 4.0 p-10 -149.5 91.61 1.84 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.189 0.995 . . . . 0.0 110.067 167.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HD1' ' A' ' 44' ' ' TYR . 24.1 mp0 -129.0 120.93 26.9 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.86 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 42' ' ' LEU . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.461 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 57' ' ' LEU . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 HE21 ' A' ' 55' ' ' GLN . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.476 HG21 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 106' ' ' PHE . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.981 HG13 HG22 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG23 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.981 HG22 HG13 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.1 111.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.403 ' NE1' ' HA ' ' A' ' 2' ' ' SER . 64.7 m95 -69.03 -167.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.771 -173.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -57.14 -8.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -78.08 -2.91 39.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.0 110.669 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.03 136.54 48.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -123.74 155.85 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -116.63 147.52 41.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 110.942 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.03 -74.79 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.146 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.22 78.98 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 0.0 111.331 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.8 mt -100.68 13.58 34.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.369 0.604 . . . . 0.0 109.567 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -128.89 115.3 19.05 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.636 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.6 Cg_exo -66.06 154.8 72.58 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.82 2.346 . . . . 0.0 111.473 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 39.5 Cg_exo -61.08 93.9 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.016 2.477 . . . . 0.0 112.677 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -87.44 112.65 22.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -86.3 114.69 58.81 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.374 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.3 77.47 2.06 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.756 2.304 . . . . 0.0 111.843 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.41 48.09 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.744 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.614 -179.505 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -111.27 128.57 55.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.6 144.23 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.587 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo -78.76 141.27 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.42 131.6 48.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.613 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.18 83.98 4.42 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.707 0.289 . . . . 0.0 110.345 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 34.19 66.73 0.25 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.567 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -106.09 31.38 5.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.241 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -102.57 -64.48 1.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.337 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 54.07 58.29 5.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.238 0.542 . . . . 0.0 110.848 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.347 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -105.17 78.13 1.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.979 0.419 . . . . 0.0 111.195 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.17 71.72 10.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.428 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.87 -95.82 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.952 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -82.73 132.05 35.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 109' ' ' VAL . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 97' ' ' LEU . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' HD13 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 61' ' ' LEU . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG23 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' OH ' HG21 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' OD1' ' A' ' 54' ' ' ASP . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.94 100.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m 74.41 -71.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.586 0.755 . . . . 0.0 111.88 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.8 p -151.36 -54.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -96.93 -23.22 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.119 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 68.17 112.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.362 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.89 -16.58 63.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' CG ' HE21 ' A' ' 55' ' ' GLN . 3.7 m-20 -83.95 -2.52 56.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.243 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 64.19 38.86 7.92 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.729 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 45' ' ' VAL . 11.3 m-20 70.07 121.09 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.92 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.464 HE21 ' CG ' ' A' ' 52' ' ' ASP . 60.5 mt-30 -99.86 116.27 31.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.45 HG21 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.719 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.615 ' CD2' HG23 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.416 ' HG3' ' HG ' ' A' ' 122' ' ' LEU . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 121' ' ' GLU . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG11 ' CB ' ' A' ' 81' ' ' ALA . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.506 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.567 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 106' ' ' PHE . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.35 119.26 52.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.654 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 47.2 m95 -93.9 142.3 27.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 77.7 m-20 65.83 -40.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.605 1.191 . . . . 0.0 113.712 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -119.8 40.16 3.47 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.439 -0.163 . . . . 0.0 111.369 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.719 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 32.1 tt0 -63.25 116.61 5.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.35 125.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.085 0.865 . . . . 0.0 109.373 -170.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -81.28 69.4 7.89 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.336 0.588 . . . . 0.0 110.792 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.83 -46.64 5.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.256 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.68 120.97 31.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.8 mt -116.05 34.61 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.995 0.426 . . . . 0.0 110.09 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -117.56 100.78 52.7 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.721 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.89 135.89 64.58 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.495 2.13 . . . . 0.0 111.435 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.84 117.29 3.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.81 2.34 . . . . 0.0 112.067 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -70.58 97.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -101.76 125.36 37.4 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.325 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.4 75.63 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.564 2.176 . . . . 0.0 111.427 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -70.58 -33.51 67.36 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.194 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.673 179.288 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.274 0.559 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -110.4 101.52 10.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.327 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.678 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER -107.16 148.37 11.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.911 -174.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 423' ' ' MET . . . . . 0.678 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo -65.25 141.08 67.35 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 427' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 13.1 ptm180 -92.26 172.36 8.46 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.522 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.55 160.99 15.14 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -81.04 45.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.743 0.782 . . . . 0.0 110.795 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -119.12 41.68 3.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.976 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -92.27 117.89 30.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.983 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 58.56 51.56 7.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.51 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.154 179.617 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 73.62 85.54 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.552 0.692 . . . . 0.0 111.826 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 43.8 mtt -87.13 68.38 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.956 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 69.07 -110.41 3.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.515 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -72.0 116.19 12.11 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.575 HD13 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD22 ' A' ' 97' ' ' LEU . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 1.9 p-10 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.418 HG23 HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 67' ' ' VAL . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.818 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.701 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.575 ' CH2' HD13 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HB3' ' A' ' 53' ' ' HIS . . . -115.37 112.96 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m 61.98 -89.7 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 O-C-N 124.273 0.631 . . . . 0.0 111.368 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -160.51 -32.98 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.096 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -58.07 -42.36 85.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.555 0.217 . . . . 0.0 111.283 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.1 p 45.12 79.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.26 -52.88 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -100.85 13.4 35.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 48.8 m-70 -135.96 54.99 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.975 -172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 7.5 p-10 -149.05 93.97 2.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.973 0.892 . . . . 0.0 108.842 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -127.84 122.61 33.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.901 -170.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 37' ' ' ASP . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.661 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.818 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' CYS . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' ' HE1' ' A' ' 53' ' ' HIS . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.732 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE1' HD12 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' HD13 ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.919 HG13 HG22 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.431 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 81' ' ' ALA . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.492 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.547 HH11 HG21 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.919 HG22 HG13 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 156' ' ' GLU . 24.1 t -106.31 136.32 41.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.53 -170.25 1.92 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.1 -12.76 54.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.262 0.553 . . . . 0.0 110.5 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -61.46 -49.05 78.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.004 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 37.5 tt0 54.97 64.82 1.68 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 159' ' ' GLY . 51.0 t30 -153.07 -16.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.241 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.2 pm0 -80.69 28.59 0.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.585 0.707 . . . . 0.0 110.413 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 157' ' ' ASN . . . -95.88 -37.32 4.99 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.106 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.83 45.89 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.358 0.599 . . . . 0.0 110.604 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 158' ' ' GLU . 60.0 mt -68.69 -37.67 79.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.067 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -121.09 86.26 42.26 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.449 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 Cg_exo -61.72 129.77 28.94 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.312 2.008 . . . . 0.0 111.232 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 35.3 Cg_exo -60.71 130.04 31.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.723 2.282 . . . . 0.0 112.441 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.62 147.97 37.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.762 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -111.31 134.71 21.06 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.129 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.25 60.09 3.9 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.559 2.173 . . . . 0.0 112.216 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -98.92 41.46 2.21 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.993 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.947 -179.443 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.643 0.259 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.36 112.75 20.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.927 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.35 147.02 19.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 66' ' ' PRO . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.479 ' HB3' HG13 ' A' ' 62' ' ' VAL . 74.5 Cg_endo -70.52 137.55 33.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.03 117.55 21.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -75.48 101.6 4.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 ptpt -76.16 50.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.079 -175.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -117.18 31.25 6.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.933 0.397 . . . . 0.0 111.239 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 162.23 37.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 56.34 36.84 28.17 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.603 0.565 . . . . 0.0 111.403 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.352 -178.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.43 78.87 1.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 110.978 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.75 58.17 4.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.958 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 81.35 -53.27 4.64 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -125.63 138.16 53.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD13 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 29' ' ' GLU . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 109' ' ' VAL . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 139' ' ' ILE . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' SER . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 97' ' ' LEU . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.404 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB2' HG23 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' HD13 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' OH ' HG21 ' A' ' 93' ' ' THR . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG13 ' OG ' ' A' ' 50' ' ' SER . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.12 86.8 1.43 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.4 m 62.08 -89.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.981 0.512 . . . . 0.0 110.197 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.511 ' H ' ' HD2' ' A' ' 49' ' ' ARG . 22.8 m -145.59 19.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.081 0.467 . . . . 0.0 109.88 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -121.27 -60.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.044 -176.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.484 ' OG ' HG13 ' A' ' 45' ' ' VAL . 13.3 m 67.74 100.2 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.817 0.698 . . . . 0.0 111.105 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.5 -34.58 72.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -84.69 12.27 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.693 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 63.05 41.27 8.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 50' ' ' SER . 35.1 m-20 69.72 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.543 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 -108.43 115.94 31.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.573 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.73 HG12 HD12 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 84' ' ' ILE . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.699 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.428 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB2' HD13 ' A' ' 151' ' ' ILE . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.633 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.629 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.436 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.56 HG23 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.629 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 11' ' ' VAL . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.428 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t -94.92 112.3 27.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.571 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 60.4 m95 -75.25 -172.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.578 176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 35' ' ' LYS . 19.0 t70 -75.4 73.33 2.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.692 0.758 . . . . 0.0 110.019 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -158.88 -118.67 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.169 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -165.79 59.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.069 0.461 . . . . 0.0 109.844 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -174.07 158.4 3.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.748 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.456 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 5.7 pt-20 -119.28 52.46 1.08 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.589 0.709 . . . . 0.0 109.96 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.59 49.33 1.11 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.227 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.6 38.89 29.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 111.475 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 158' ' ' GLU . 58.1 mt -105.34 1.3 27.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.422 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 158' ' ' GLU . 2.1 m-85 -120.53 89.64 44.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.763 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.76 133.15 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.21 1.94 . . . . 0.0 111.888 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.22 75.92 2.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.667 2.245 . . . . 0.0 111.94 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.62 144.2 56.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.12 115.98 65.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.211 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.07 143.39 84.38 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.723 2.282 . . . . 0.0 111.834 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.64 -117.23 4.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.795 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.692 -179.43 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.5 mt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.449 0.642 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -146.33 120.12 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.491 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.413 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -77.29 159.64 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 70' ' ' ASN . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.73 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 425' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo -82.34 83.54 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -63.21 131.99 50.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.735 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -84.01 92.34 7.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.206 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.05 -26.09 63.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 430' ' ' ALA . . . . . 0.491 ' HB3' ' OG ' ' A' ' 59' ' ' SER . . . -145.8 81.99 1.62 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.849 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -84.74 162.55 19.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.447 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.41 126.98 31.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.409 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.258 -178.359 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.97 104.38 12.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -94.29 63.74 3.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.255 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 74.31 -74.52 1.24 Allowed Glycine 0 N--CA 1.453 -0.197 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -117.61 125.44 50.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.63 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.599 HD13 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.549 HD11 HG21 ' A' ' 109' ' ' VAL . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 139' ' ' ILE . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.404 HG23 HG11 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD23 HG22 ' A' ' 65' ' ' VAL . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HD2' ' OD2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.24 127.45 7.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.8 m 69.69 -74.43 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 t -158.7 -50.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 110.066 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.27 -100.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 t 171.78 128.05 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 123.555 0.534 . . . . 0.0 111.537 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.8 mt -104.27 -67.43 0.9 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -117.23 23.69 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.812 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 54.1 m-70 -133.25 66.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -169.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 19.2 p-10 -149.4 76.94 1.33 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.518 1.151 . . . . 0.0 109.821 167.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.82 116.99 28.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.595 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 38' ' ' LEU . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.494 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 422' ' ' THR . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 80' ' ' SER . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.727 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.619 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.667 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 11' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.727 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 108' ' ' ARG . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.45 123.47 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 90.0 m95 -100.39 134.46 43.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -169.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 21.7 t70 57.86 -57.99 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.345 1.653 . . . . 0.0 113.595 175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 153' ' ' TRP . 31.1 m-80 -96.21 46.49 1.07 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 122.942 0.497 . . . . 0.0 110.944 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 42.0 tt0 -78.05 96.6 5.15 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.525 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 33.7 t30 70.22 134.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 122.127 0.965 . . . . 0.0 112.602 171.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.87 69.48 0.71 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.3 55.34 5.03 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.647 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.17 73.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.093 0.473 . . . . 0.0 110.034 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.65 10.08 1.93 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.941 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -118.43 93.34 45.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 51.7 Cg_exo -55.97 135.88 71.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.092 2.528 . . . . 0.0 112.455 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 59.9 Cg_endo -88.43 85.49 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.659 2.24 . . . . 0.0 111.801 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.72 106.72 11.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.265 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -76.56 119.54 77.8 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.58 65.59 8.62 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.701 2.267 . . . . 0.0 112.391 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.99 46.8 3.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.115 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.165 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 65.0 tp . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.784 0.326 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 420' ' ' ALA . . . . . 0.423 ' C ' HG13 ' B' ' 421' ' ' ILE . . . -87.64 134.51 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.33 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 421' ' ' ILE . . . . . 0.585 HG22 ' H ' ' B' ' 422' ' ' THR . 0.9 OUTLIER 57.0 -179.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.936 -176.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 422' ' ' THR . . . . . 0.585 ' H ' HG22 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 426' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 62' ' ' VAL . 72.6 Cg_endo -71.95 104.61 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -63.75 135.0 56.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -70.61 172.21 9.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -76.05 53.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.582 0.706 . . . . 0.0 112.146 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.54 31.72 5.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -78.7 -26.34 44.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.828 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -81.5 62.53 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.641 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.766 -179.179 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 28' ' ' PHE . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD13 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CD1' HD22 ' A' ' 97' ' ' LEU . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.627 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.816 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.484 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' HA ' HD13 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 62' ' ' VAL . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CH2' HD13 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB2' HD21 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 5.7 pt20 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 121.11 0.481 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' B' ' 426' ' ' PRO . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.568 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' A' ' 34' ' ' LEU . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.621 ' CD2' HG23 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.425 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.503 HG11 ' HB1' ' A' ' 81' ' ' ALA . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.582 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.586 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.489 ' HB2' HD12 ' A' ' 60' ' ' ILE . 60.3 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 109' ' ' VAL . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 136' ' ' VAL . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' ASP . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.674 HD11 HD11 ' A' ' 97' ' ' LEU . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HD13 ' A' ' 7' ' ' LEU . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' A' ' 7' ' ' LEU . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' O ' HG13 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.628 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.739 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.675 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' OD1' HD23 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD11 HD11 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 151' ' ' ILE . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.943 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.601 HG11 ' HB1' ' A' ' 81' ' ' ALA . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 19' ' ' THR . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.58 ' HA ' HG12 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.452 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.943 HG22 HG13 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.579 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.499 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 96.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 28' ' ' PHE . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 109' ' ' VAL . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 24' ' ' PHE . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.498 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.481 HG23 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 97' ' ' LEU . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.543 ' HA ' HD13 ' A' ' 7' ' ' LEU . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.658 ' HB2' HG23 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 94' ' ' VAL . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.489 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 62' ' ' VAL . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 424' ' ' LEU . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.498 ' OG1' HG23 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.564 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' CD1' HG23 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.503 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.498 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 136' ' ' VAL . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 89' ' ' LEU . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 135' ' ' ILE . 27.7 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 11' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.568 HG22 ' H ' ' B' ' 422' ' ' THR . 1.3 mt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.568 ' H ' HG22 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . 0.497 ' HE1' ' O ' ' A' ' 71' ' ' LYS . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.475 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo . . . . . 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' CD1' ' A' ' 28' ' ' PHE . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.491 HD13 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 109' ' ' VAL . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.641 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.587 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' A' ' 7' ' ' LEU . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD23 HG22 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' HB3' ' HG3' ' A' ' 55' ' ' GLN . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.839 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' B' ' 422' ' ' THR . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.536 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 55' ' ' GLN . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 116' ' ' GLU . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.625 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' SER . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' SER . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HD2' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.561 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.492 ' C ' HD22 ' A' ' 125' ' ' ASN . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.492 HD22 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.456 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.548 HD12 HG13 ' A' ' 11' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 140' ' ' LEU . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 148' ' ' ARG . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.422 HG21 ' HD2' ' A' ' 66' ' ' PRO . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . 0.412 ' CE ' ' HB3' ' A' ' 71' ' ' LYS . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.536 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.515 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo . . . . . 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 28' ' ' PHE . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.49 HD13 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 109' ' ' VAL . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.733 HD11 HD11 ' A' ' 97' ' ' LEU . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.618 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.638 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.749 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' OE1' ' A' ' 56' ' ' GLU . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB2' HD21 ' A' ' 57' ' ' LEU . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 pm0 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 37' ' ' ASP . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.626 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 26' ' ' ILE . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' CE2' HD12 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 151' ' ' ILE . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.408 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.464 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.482 ' CG2' HD21 ' A' ' 89' ' ' LEU . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 41.9 t30 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.577 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 106' ' ' PHE . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.518 HG23 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.481 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.527 ' HB3' HG13 ' A' ' 62' ' ' VAL . 88.8 Cg_endo . . . . . 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 38' ' ' LEU . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.543 HD13 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.562 HG13 HD12 ' A' ' 139' ' ' ILE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 136' ' ' VAL . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 7' ' ' LEU . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.699 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 61' ' ' LEU . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 57' ' ' LEU . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' HD1' ' OE1' ' A' ' 55' ' ' GLN . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' THR . . . . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HD1' ' A' ' 44' ' ' TYR . 24.1 mp0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 42' ' ' LEU . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.461 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 57' ' ' LEU . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 HE21 ' A' ' 55' ' ' GLN . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.476 HG21 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 106' ' ' PHE . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.981 HG13 HG22 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG23 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.981 HG22 HG13 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.587 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 109' ' ' VAL . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 97' ' ' LEU . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' HD13 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 61' ' ' LEU . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG23 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' OH ' HG21 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 43' ' ' THR . 60.5 mt-30 . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.45 HG21 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.615 ' CD2' HG23 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.416 ' HG3' ' HG ' ' A' ' 122' ' ' LEU . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 121' ' ' GLU . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG11 ' CB ' ' A' ' 81' ' ' ALA . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.506 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.567 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 106' ' ' PHE . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.678 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.478 0 CA-C-O 121.432 0.634 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . 0.678 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo . . . . . 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.575 HD13 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD22 ' A' ' 97' ' ' LEU . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 8.6 p30 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.418 HG23 HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 67' ' ' VAL . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.818 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.701 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.575 ' CH2' HD13 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 94' ' ' VAL . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.287 0.089 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 37' ' ' ASP . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.661 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.818 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' CYS . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.732 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE1' HD12 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' HD13 ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.919 HG13 HG22 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.431 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 81' ' ' ALA . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.492 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.547 HH11 HG21 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.919 HG22 HG13 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.515 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 66' ' ' PRO . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.479 ' HB3' HG13 ' A' ' 62' ' ' VAL . 74.5 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 HD13 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 29' ' ' GLU . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 109' ' ' VAL . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 139' ' ' ILE . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' SER . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 97' ' ' LEU . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.404 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB2' HG23 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' HD13 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' OH ' HG21 ' A' ' 93' ' ' THR . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.643 0.258 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.573 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.73 HG12 HD12 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 84' ' ' ILE . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.699 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.428 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB2' HD13 ' A' ' 151' ' ' ILE . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.633 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.629 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.436 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.56 HG23 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.629 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 11' ' ' VAL . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.428 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t . . . . . 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.413 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.533 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 70' ' ' ASN . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.73 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo . . . . . 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 28' ' ' PHE . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.599 HD13 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.549 HD11 HG21 ' A' ' 109' ' ' VAL . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 139' ' ' ILE . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.404 HG23 HG11 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD23 HG22 ' A' ' 65' ' ' VAL . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 38' ' ' LEU . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.494 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 422' ' ' THR . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 80' ' ' SER . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.727 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.619 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.667 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 11' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.727 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 108' ' ' ARG . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 421' ' ' ILE . . . . . 0.585 HG22 ' H ' ' B' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.597 0.713 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . 0.585 ' H ' HG22 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 424' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 426' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 62' ' ' VAL . 72.6 Cg_endo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -112.06 86.71 2.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.086 0.47 . . . . 0.0 110.737 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . 0.475 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 1.8 mpt? -83.8 65.48 8.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.331 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 68.5 -107.72 2.19 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.72 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 p -80.73 115.66 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.88 -23.38 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 111.09 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.557 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 94.6 t -131.78 126.93 58.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.967 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 13.2 t -131.06 137.43 49.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD13 ' CH2' ' A' ' 40' ' ' TRP . 32.4 tp -88.14 118.2 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.1 mp -74.47 -31.03 62.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.761 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.28 -177.02 36.0 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.203 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' CD1' HD22 ' A' ' 97' ' ' LEU . 6.9 mt -132.39 140.17 48.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 39.2 tptt -102.01 105.19 15.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.331 0.586 . . . . 0.0 109.955 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 139' ' ' ILE . 56.1 t -70.21 97.43 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.292 171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 1.3 mt -75.5 -35.65 60.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.554 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.45 98.82 10.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 m-20 -167.71 117.01 0.67 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.765 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.2 Cg_endo -81.94 152.85 77.46 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.819 -3.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.82 178.59 6.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.591 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -100.75 164.91 11.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 170.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.627 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 84.9 t80 -72.51 -38.26 68.15 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.434 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.52 13.79 4.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 110.993 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 22.2 t70 -97.16 138.7 21.24 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.078 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.0 Cg_exo -53.82 138.14 68.49 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.996 2.464 . . . . 0.0 113.662 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -84.5 117.07 23.45 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.164 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.14 112.45 18.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.317 0.579 . . . . 0.0 110.977 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 68.9 m-85 -121.55 135.31 55.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.912 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 33.4 tt0 -101.71 122.39 43.82 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.672 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.816 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -87.95 132.87 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.34 -176.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.484 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 58.9 m -131.69 114.46 14.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.655 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' HA ' HD13 ' A' ' 7' ' ' LEU . 46.4 p90 -140.38 160.18 40.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.684 0.278 . . . . 0.0 110.54 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -106.29 120.34 41.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.58 112.07 23.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.988 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.475 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.8 mm? -77.61 -39.42 45.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -137.24 144.51 42.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -60.71 122.99 16.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 110.08 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' CE2' ' A' ' 101' ' ' TYR . 3.3 mm? -67.92 127.64 33.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.29 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -79.77 -19.23 49.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.617 176.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.0 m-70 -112.67 -174.59 2.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -108.66 151.46 26.13 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.907 0.384 . . . . 0.0 111.297 -173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 62' ' ' VAL . 71.8 mt -100.78 125.59 47.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.084 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.3 tt0 -109.46 115.18 29.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CH2' HD13 ' A' ' 6' ' ' LEU . 88.3 m95 -107.4 136.5 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -147.74 159.53 43.71 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.907 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -117.33 131.0 56.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.1 m -118.84 134.95 54.81 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB2' HD21 ' A' ' 57' ' ' LEU . 71.5 t80 -97.3 128.6 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.26 116.38 48.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.184 -175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.62 89.94 0.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.286 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.8 m 69.83 -76.2 0.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.658 0.783 . . . . 0.0 112.051 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.0 t -142.61 -62.59 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.891 -0.506 . . . . 0.0 111.759 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.2 -0.65 55.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.876 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m 66.69 81.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.907 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.7 -10.04 56.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.237 0.542 . . . . 0.0 110.616 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 13.0 p-10 -100.84 1.88 40.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.551 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 30.8 m-70 67.37 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.012 0.82 . . . . 0.0 109.473 -171.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -48.2 131.01 16.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 110.963 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 5.7 pt20 -130.28 122.51 28.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.437 -172.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.65 112.09 11.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.264 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.0 mm? -77.43 -30.16 53.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.295 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.46 148.9 0.96 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -140.6 128.92 22.45 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.107 0.479 . . . . 0.0 110.833 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' B' ' 426' ' ' PRO . 41.5 pt -115.48 154.59 16.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.069 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.01 132.18 47.48 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -118.52 134.68 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.323 0.582 . . . . 0.0 111.729 -175.008 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.29 152.1 8.31 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.849 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.95 129.34 17.86 Favored 'Cis proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.899 -1.709 . . . . 0.0 111.804 -5.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -95.16 112.82 59.85 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.353 0.597 . . . . 0.0 110.665 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -88.03 169.49 6.37 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.826 3.017 . . . . 0.0 113.74 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -70.73 144.87 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.741 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.85 -163.99 14.26 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.8 138.33 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.8 OUTLIER -110.55 137.07 48.71 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HA ' ' B' ' 423' ' ' MET . 38.9 ttmt -147.29 128.49 14.73 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -172.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' B' ' 423' ' ' MET . 14.1 p90 -161.84 159.23 26.66 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.4 129.79 42.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.433 0.635 . . . . 0.0 109.965 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -109.95 118.59 36.87 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.517 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -112.6 123.9 51.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.821 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 134.45 54.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 25.5 t70 -64.02 131.93 95.12 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.631 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 54.1 Cg_endo -68.62 150.06 74.37 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.865 2.376 . . . . 0.0 112.458 -174.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 3.1 Cg_exo -76.42 147.1 28.42 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.883 2.389 . . . . 0.0 111.634 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 m -82.45 137.6 34.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.662 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -68.49 -14.27 62.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.734 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.43 -23.72 40.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 110.846 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -80.24 -31.85 38.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.348 0.594 . . . . 0.0 110.326 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -125.44 101.89 30.41 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 -178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.42 161.61 1.14 Allowed 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 123.458 2.772 . . . . 0.0 113.165 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.36 -43.79 23.45 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 p -79.26 -11.02 59.95 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.55 -25.24 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -95.36 -8.77 34.75 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.673 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 86' ' ' ALA . 48.2 t -83.97 62.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.121 0.962 . . . . 0.0 109.056 172.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.1 m -148.56 165.19 32.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.737 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.5 m -80.13 132.73 31.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.292 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 p -126.98 178.55 5.91 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.018 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -128.67 134.16 65.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.309 0.576 . . . . 0.0 110.601 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 43.7 mt -105.49 134.95 45.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -117.45 118.78 33.14 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.238 0.542 . . . . 0.0 111.056 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 26' ' ' ILE . 2.2 tt -101.89 116.7 33.27 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 15.8 p -131.52 135.23 46.89 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.834 -170.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.568 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 42.9 t -113.09 133.49 54.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.394 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 7.8 m -120.12 130.46 54.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.849 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE2' HD12 ' A' ' 34' ' ' LEU . 87.9 t80 -110.78 106.81 16.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 t70 57.71 35.8 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.386 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.24 -20.55 50.05 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.211 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 156' ' ' GLU . 38.3 mtp180 -92.59 114.46 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.492 0.646 . . . . 0.0 111.09 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 98' ' ' SER . 16.1 tt0 -85.38 121.77 28.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.411 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.621 ' CD2' HG23 ' A' ' 107' ' ' VAL . 11.9 p90 -112.49 -19.47 12.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.644 -176.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 106' ' ' PHE . 40.2 t -135.65 119.75 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.619 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -133.13 117.4 17.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.76 128.09 64.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.173 -173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.56 141.0 15.3 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.26 136.86 45.79 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.89 138.79 31.2 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.582 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -118.74 128.62 75.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.117 0.484 . . . . 0.0 111.4 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -84.76 117.04 23.59 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.292 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 40.2 m-80 -116.63 122.21 43.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.425 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.2 pt-20 -156.06 167.16 31.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.112 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -89.16 121.79 31.82 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 17.6 t70 -66.72 -14.59 62.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.587 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -94.59 118.72 32.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.499 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 35.5 tt0 -57.98 -37.49 74.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.342 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.66 -34.82 79.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.758 0.313 . . . . 0.0 110.918 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.95 -33.98 24.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NH2' ' HG3' ' A' ' 120' ' ' GLU . 56.3 ttp180 -61.49 -44.91 96.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.576 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 50.1 mm-40 -76.98 -44.91 29.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -115.38 94.15 38.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.56 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.65 131.38 19.88 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.972 2.448 . . . . 0.0 112.043 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.23 165.29 28.06 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.584 2.19 . . . . 0.0 112.426 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.29 -48.17 79.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.238 0.542 . . . . 0.0 110.629 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.83 131.89 36.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.503 HG11 ' HB1' ' A' ' 81' ' ' ALA . 6.9 p -71.04 123.85 26.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.492 0.663 . . . . 0.0 110.287 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.92 75.89 1.22 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -63.7 -21.83 29.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.171 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.6 -16.41 60.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.777 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -112.83 5.27 17.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.598 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 130' ' ' VAL . 62.3 mt -94.21 128.05 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.3 t -97.07 128.31 48.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.457 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ttp85 -105.03 110.76 23.28 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.623 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -118.98 109.02 15.47 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.582 HG12 ' CG1' ' A' ' 113' ' ' VAL . 5.4 mt -79.19 125.39 38.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.277 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.68 70.66 5.06 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.55 -10.08 56.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.38 -23.92 64.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.897 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -128.41 96.74 29.88 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 121.243 0.544 . . . . 0.0 111.093 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -82.18 125.58 4.66 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.195 2.596 . . . . 0.0 111.401 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -102.36 100.34 10.48 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 109' ' ' VAL . 20.0 t -104.32 131.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.014 -174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.586 ' HB ' ' CD ' ' A' ' 108' ' ' ARG . 8.5 m -125.39 126.23 44.67 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -110.05 129.49 55.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -106.89 131.53 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.35 111.59 10.78 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.215 0.531 . . . . 0.0 110.072 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.6 pt -118.34 172.13 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' OE1' ' A' ' 156' ' ' GLU . 60.1 t -107.67 120.24 58.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.557 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 59.0 m95 -97.29 137.49 36.22 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.641 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 35' ' ' LYS . 36.9 t0 64.52 -59.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.749 1.281 . . . . 0.0 113.342 174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -88.85 31.77 0.84 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.534 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.47 ' OE2' HD21 ' A' ' 161' ' ' LEU . 52.5 tt0 -96.25 136.55 36.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.992 0.425 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -87.36 134.34 33.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.05 126.35 30.59 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.106 0.479 . . . . 0.0 111.204 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -148.21 -63.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.124 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -124.41 80.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.11 0.481 . . . . 0.0 110.189 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.47 HD21 ' OE2' ' A' ' 156' ' ' GLU . 83.2 mt -106.36 -1.65 23.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 78.1 m-85 -116.75 124.93 28.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.788 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 162' ' ' TYR . 42.9 Cg_exo -57.35 134.85 66.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.878 2.385 . . . . 0.0 112.172 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.62 106.97 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.754 2.303 . . . . 0.0 111.765 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 112.9 5.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.167 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -103.82 146.14 31.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.07 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.28 88.29 0.72 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.621 2.214 . . . . 0.0 112.505 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.6 162.75 50.95 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.625 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.251 1.18 0 CA-C-O 119.097 -0.478 . . . . 0.0 110.106 -177.686 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -131.91 157.46 43.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.071 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 177.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 110.356 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 85.0 m -148.69 107.24 3.79 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.332 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -73.21 -26.59 61.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 -173.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER 61.06 -173.76 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 110.6 -178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -140.36 80.43 19.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.489 ' HB2' HD12 ' A' ' 60' ' ' ILE . 60.3 Cg_endo -69.15 103.96 1.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.451 2.101 . . . . 0.0 111.936 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -67.32 166.01 15.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.064 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -99.46 88.12 3.79 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 59.5 -100.03 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.712 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . 46.39 50.03 12.74 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.814 0.696 . . . . 0.0 112.243 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -76.99 144.11 38.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.548 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -136.9 140.36 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . 0.41 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.885 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -144.13 76.6 1.51 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 110.846 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.94 68.01 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.174 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 79.16 -86.54 1.2 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.695 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HD23 ' A' ' 31' ' ' LEU . 23.6 t -94.03 135.72 35.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 mm -70.23 -29.28 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.276 0.56 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 28' ' ' PHE . 46.0 t -126.21 116.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.752 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 28.7 t -118.61 131.69 56.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.0 tp -86.45 116.25 24.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.3 mp -73.6 -34.25 64.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.586 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.02 177.86 37.11 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.24 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 109' ' ' VAL . 6.0 mt -127.65 143.18 41.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.1 tptt -105.57 113.07 26.42 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.952 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 139' ' ' ILE . 48.3 t -68.5 98.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.186 169.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -68.38 -30.15 69.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.954 0.407 . . . . 0.0 110.957 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.59 95.49 6.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.445 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -154.12 108.55 2.46 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.64 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 157.77 92.69 Favored 'Cis proline' 0 C--N 1.346 0.441 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.47 -0.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.0 174.23 6.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.032 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 136' ' ' VAL . 20.3 mmmt -130.25 138.93 50.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 38.7 t80 -64.61 -35.39 80.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -164.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.485 HG23 HG11 ' A' ' 132' ' ' VAL . 6.0 p -99.54 15.0 27.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.459 . . . . 0.0 111.254 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 32.6 t70 -105.46 131.75 21.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 20' ' ' ASP . 50.6 Cg_exo -53.89 124.9 17.01 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.062 2.508 . . . . 0.0 112.951 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 75' ' ' SER . 26.6 m-85 -79.44 148.88 31.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.804 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.83 124.62 31.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.087 0.47 . . . . 0.0 110.488 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.4 m-85 -129.09 135.53 49.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.4 tt0 -98.56 121.14 40.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.653 -178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.674 HD11 HD11 ' A' ' 97' ' ' LEU . 21.4 mm -92.72 124.51 45.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.2 m -129.29 114.53 16.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.277 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HA ' HD13 ' A' ' 7' ' ' LEU . 48.2 p90 -138.21 162.37 34.46 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.83 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' A' ' 7' ' ' LEU . 4.5 tp10 -103.61 118.93 37.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.542 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' O ' HG13 ' A' ' 67' ' ' VAL . 33.6 t -91.33 102.92 15.62 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 2' ' ' SER . 2.9 mm? -73.94 -31.07 62.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 0.0 110.489 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -143.97 143.54 31.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -62.3 120.48 11.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.036 0.446 . . . . 0.0 110.93 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -73.72 108.25 6.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.839 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -77.11 -20.44 55.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.866 0.365 . . . . 0.0 110.256 177.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.667 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m-70 -93.72 -179.07 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.628 ' HB3' HD21 ' A' ' 61' ' ' LEU . 18.7 m-20 -95.09 137.41 34.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.18 0.514 . . . . 0.0 111.793 -173.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.739 ' HB2' HG23 ' A' ' 62' ' ' VAL . 80.9 mt -96.6 127.41 42.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.091 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -115.48 122.57 46.14 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.745 0.307 . . . . 0.0 110.655 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CH2' HD13 ' A' ' 6' ' ' LEU . 74.5 m95 -114.04 137.52 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -148.2 160.68 42.68 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.399 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.8 122.53 47.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 m -111.51 132.44 54.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.929 0.395 . . . . 0.0 110.407 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 44.9 t80 -90.4 120.76 31.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG13 ' OG ' ' A' ' 50' ' ' SER . 34.1 t -115.27 123.11 70.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.043 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 96.32 1.6 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.619 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.1 m 71.55 -71.32 0.14 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.416 0.686 . . . . 0.0 112.323 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -142.16 -67.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -93.4 -2.07 55.08 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.872 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.536 ' OG ' HG13 ' A' ' 45' ' ' VAL . 15.1 m 68.27 101.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.469 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -65.38 -20.95 66.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.632 0.729 . . . . 0.0 109.854 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' HG3' ' A' ' 55' ' ' GLN . 7.4 p-10 -88.88 -2.4 58.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.15 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 69.85 28.69 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 111.919 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 50' ' ' SER . 11.1 m-20 69.43 131.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.753 0.821 . . . . 0.0 110.69 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 67.2 mt-30 -120.74 116.17 24.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.433 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' OE1' ' HG3' ' A' ' 41' ' ' LYS . 43.5 tt0 -87.99 106.16 17.94 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 2.2 mm? -75.26 -61.07 2.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.069 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -142.75 158.59 43.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.305 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 p -138.56 140.82 39.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.0 110.801 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.9 pt -115.22 148.95 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.636 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.3 tm? -121.67 135.62 54.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 -171.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.25 134.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.09 178.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 147.94 151.62 5.48 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.677 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 21.0 Cg_exo -67.4 135.66 29.45 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.338 -1.526 . . . . 0.0 111.852 -5.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.675 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -103.09 131.61 21.96 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.715 0.293 . . . . 0.0 110.241 -178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.5 Cg_exo -67.5 158.69 55.93 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.431 2.754 . . . . 0.0 113.529 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 30' ' ' CYS . 23.8 t -70.65 141.6 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.431 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.98 -169.79 17.89 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -78.73 134.31 28.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 118.288 1.044 . . . . 0.0 108.193 175.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' OD1' HD23 ' B' ' 424' ' ' LEU . 37.9 m-80 -110.97 136.39 50.05 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 17.6 ttmm -144.03 133.73 23.69 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' CB ' ' HD3' ' B' ' 426' ' ' PRO . 8.1 p90 -165.83 157.66 14.34 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 123.72 0.637 . . . . 0.0 109.973 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.16 129.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.428 0.633 . . . . 0.0 110.052 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -106.91 112.68 25.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.919 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.2 t -109.93 119.93 40.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.878 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.67 56.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.227 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 7.6 m-20 -68.17 139.02 92.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.208 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.1 150.67 17.93 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.854 2.369 . . . . 0.0 113.494 -171.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.72 155.53 68.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.148 2.565 . . . . 0.0 112.155 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.7 t -91.39 141.21 29.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.647 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -69.32 -12.91 62.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -55.51 -20.76 13.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 111.139 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.98 -30.47 24.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.48 104.97 30.89 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.74 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -50.72 160.71 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.373 2.715 . . . . 0.0 113.17 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.1 -47.14 34.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -79.85 -0.91 36.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.45 -25.84 13.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.87 -19.41 18.87 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.517 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 116' ' ' GLU . 58.8 t -80.95 66.47 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.022 0.915 . . . . 0.0 110.391 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.7 m -149.15 178.72 8.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.839 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.55 127.52 39.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.342 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 p -118.12 178.07 4.56 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.81 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.1 t -127.11 136.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.06 0.457 . . . . 0.0 110.321 -176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 84.8 mt -107.97 134.51 49.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.263 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 83.2 mt -118.14 121.35 40.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.794 0.33 . . . . 0.0 110.646 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD11 HD11 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -99.49 115.86 30.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 172.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.4 m -117.93 135.04 54.38 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.957 -171.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 49.1 t -115.84 125.64 52.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.769 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.7 m -123.45 134.69 53.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 43.3 t80 -109.58 111.97 23.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 56.81 31.55 19.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.677 0.751 . . . . 0.0 110.159 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.1 -12.68 62.13 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.742 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -94.96 115.35 27.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.818 0.809 . . . . 0.0 111.659 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.81 122.07 28.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 151' ' ' ILE . 15.8 p90 -117.86 -23.66 7.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.493 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -127.99 120.26 53.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 0.0 110.891 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.4 ptp180 -132.36 125.0 29.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.255 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.943 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -113.52 116.62 53.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.08 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.94 146.64 16.12 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.928 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 92.2 m-85 -137.96 150.71 47.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.452 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 48.4 m-85 -97.91 138.67 34.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.09 129.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.342 -176.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -83.7 116.26 22.57 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.82 177.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 47.7 m-20 -105.91 121.28 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.6 pt-20 -152.71 161.3 42.75 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 34.8 m-85 -83.65 120.74 26.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.92 -11.4 27.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.154 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.5 117.49 31.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.132 0.491 . . . . 0.0 110.073 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.96 -41.78 78.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.009 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.05 -31.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -72.04 -39.29 69.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 0.0 109.733 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -70.6 -45.67 64.88 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.59 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -120.82 87.12 42.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.735 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.26 123.74 10.58 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.137 1.891 . . . . 0.0 112.142 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.12 161.29 41.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.611 2.208 . . . . 0.0 111.88 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.58 -49.34 22.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 109.689 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.08 130.26 36.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.601 HG11 ' HB1' ' A' ' 81' ' ' ALA . 5.4 p -77.63 124.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.509 0.671 . . . . 0.0 110.983 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -103.64 76.62 1.41 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 19' ' ' THR . 3.2 t -64.36 -21.56 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.631 -169.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -61.64 -24.18 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.331 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 37.0 m-70 -108.25 16.63 23.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 110.632 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 130' ' ' VAL . 61.3 mt -101.43 128.76 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 49.9 t -105.53 140.35 23.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.927 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' ASN . 20.2 ttm180 -112.03 110.48 20.8 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.344 0.592 . . . . 0.0 109.694 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 31.2 t30 -100.53 114.58 28.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.58 ' HA ' HG12 ' A' ' 113' ' ' VAL . 3.8 mt -86.39 114.03 25.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.354 -177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.26 69.08 6.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -71.92 -7.36 48.08 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.061 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.24 -27.19 65.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.57 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.452 ' CE ' ' HB2' ' A' ' 112' ' ' TYR . 9.0 pttm -122.56 95.9 46.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 110.834 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.48 126.13 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.946 2.431 . . . . 0.0 111.487 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -105.01 100.77 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.943 HG22 HG13 ' A' ' 109' ' ' VAL . 18.1 t -112.38 137.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.125 0.488 . . . . 0.0 110.697 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -125.53 127.06 45.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.492 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.19 135.77 47.08 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -73.18 100.57 3.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.715 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 106' ' ' PHE . 2.2 pt -116.25 164.22 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.67 131.48 65.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -76.69 -168.1 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.312 -172.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.56 -14.21 1.97 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 111.723 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -77.84 -5.68 51.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.49 150.95 47.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.69 144.76 47.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -67.98 100.89 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 0.0 110.708 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -165.63 -71.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.571 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.31 51.47 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.26 15.12 3.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.611 0.72 . . . . 0.0 110.165 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -144.65 126.13 7.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.876 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.21 129.68 23.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.948 1.765 . . . . 0.0 111.609 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.19 86.9 1.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.532 2.154 . . . . 0.0 112.083 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.38 137.81 41.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.88 143.48 26.19 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.592 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.9 90.66 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.864 2.376 . . . . 0.0 112.307 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.31 75.12 1.14 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.537 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.103 -178.107 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -134.05 172.5 12.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.968 0.413 . . . . 0.0 110.328 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -87.43 156.52 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.111 0.958 . . . . 0.0 112.685 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 43.3 m -88.32 -35.11 17.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.78 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.77 68.59 0.82 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.318 0.58 . . . . 0.0 109.94 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.579 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.23 -44.02 84.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.055 -172.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 53.6 tptt 61.49 94.86 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -170.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.499 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 96.2 Cg_endo -78.41 134.3 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 -172.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 133.93 34.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -66.33 138.59 57.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -74.96 69.37 1.89 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.114 0.483 . . . . 0.0 112.289 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -86.66 8.13 23.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -68.87 105.29 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.715 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.64 142.25 35.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . 0.42 HD23 ' N ' ' B' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.347 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 54.08 82.64 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 111.476 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 31' ' ' LEU . 2.0 mpt? -81.63 65.59 6.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.26 -106.21 1.88 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -75.18 131.55 40.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 mm -81.82 -29.48 10.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.977 0.417 . . . . 0.0 111.763 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.665 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 87.4 t -131.1 127.02 60.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.955 0.407 . . . . 0.0 110.144 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 7.9 t -136.27 137.8 41.11 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CH2' ' A' ' 40' ' ' TRP . 36.3 tp -87.98 120.56 29.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 29' ' ' GLU . 7.5 mp -75.5 -33.32 60.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.392 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 178.25 35.39 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.593 HD11 HG21 ' A' ' 109' ' ' VAL . 3.6 mt -134.46 143.47 37.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 20.4 tttp -114.91 115.94 27.72 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 24' ' ' PHE . 3.6 m -73.94 110.91 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.137 0.97 . . . . 0.0 110.106 171.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.5 mm? -69.81 -13.03 62.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.244 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 10.4 m120 -104.64 105.08 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 m-20 -167.44 110.43 0.62 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.068 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 97.3 Cg_endo -78.93 168.57 74.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.723 -1.365 . . . . 0.0 111.623 -0.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -135.45 161.23 36.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.434 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -97.35 145.77 25.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.498 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 64.8 t80 -68.07 -22.16 64.95 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.445 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.481 HG23 HG11 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -96.03 14.12 24.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.057 0.456 . . . . 0.0 111.111 176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 7.8 t70 -98.7 147.06 32.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 20' ' ' ASP . 11.8 Cg_endo -55.42 155.37 20.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.669 2.246 . . . . 0.0 113.15 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -97.0 126.4 42.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.849 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -124.93 113.07 17.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.321 0.581 . . . . 0.0 110.668 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 11' ' ' VAL . 34.1 m-85 -120.64 134.83 55.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.753 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 38.8 tt0 -95.92 113.0 24.58 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.686 HD11 HD11 ' A' ' 97' ' ' LEU . 23.9 mm -88.72 126.23 41.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.184 0.516 . . . . 0.0 111.278 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -131.46 117.65 19.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.521 172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.543 ' HA ' HD13 ' A' ' 7' ' ' LEU . 54.7 p90 -139.37 162.12 35.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.661 0.267 . . . . 0.0 110.54 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 7' ' ' LEU . 10.3 tp10 -104.66 114.74 29.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.527 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 52.4 t -88.42 104.38 16.73 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HB3' ' SD ' ' A' ' 0' ' ' MET . 2.9 mm? -73.19 -33.49 65.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.417 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.87 146.23 35.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -66.48 124.49 22.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.975 0.417 . . . . 0.0 110.104 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -72.41 132.36 43.82 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.705 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -75.61 -27.27 58.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.163 174.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 30.4 m170 -108.71 -165.52 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.342 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -106.66 157.45 17.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.897 0.379 . . . . 0.0 111.393 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.658 ' HB2' HG23 ' A' ' 62' ' ' VAL . 78.0 mt -103.64 130.74 51.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.794 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 30.4 tt0 -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.26 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 6' ' ' LEU . 89.1 m95 -106.7 129.07 54.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 33.7 mtmt -140.44 155.07 46.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.001 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -118.77 135.83 54.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 91.4 m -122.64 133.44 54.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.756 0.313 . . . . 0.0 110.514 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' A' ' 93' ' ' THR . 68.5 t80 -94.44 127.51 40.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' A' ' 54' ' ' ASP . 39.9 t -119.4 117.28 53.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.338 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.3 104.2 1.54 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.416 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.2 m 72.04 -64.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.433 0.693 . . . . 0.0 111.837 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.8 t -166.56 -54.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.026 0.441 . . . . 0.0 110.162 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -85.81 -32.32 21.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.233 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 t 65.54 97.33 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.311 0.577 . . . . 0.0 111.018 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.2 mt -74.1 -7.89 54.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.703 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -88.6 -0.6 57.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.382 0.611 . . . . 0.0 109.484 175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 66.03 31.55 8.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.069 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 45' ' ' VAL . 53.1 m-20 68.48 141.62 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.587 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -121.1 115.52 23.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.14 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.35 109.63 10.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -72.42 -36.7 68.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.771 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -175.09 176.68 2.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.489 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 16.7 p -155.71 126.65 7.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.823 0.344 . . . . 0.0 110.594 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 41.9 pt -115.41 149.25 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.15 0.5 . . . . 0.0 109.898 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 62' ' ' VAL . 3.5 tm? -123.99 136.19 54.13 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.282 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -129.22 134.1 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.71 0.29 . . . . 0.0 111.202 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 64' ' ' PRO . . . 161.02 152.93 6.79 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.21 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' ' 63' ' ' GLY . 39.7 Cg_endo -67.62 136.08 31.82 Favored 'Cis proline' 0 C--N 1.344 0.293 0 C-N-CA 123.262 -1.557 . . . . 0.0 112.211 -4.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.52 121.41 47.24 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.509 -177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 424' ' ' LEU . 97.2 Cg_endo -87.66 169.22 6.88 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.797 2.998 . . . . 0.0 114.046 -176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.81 137.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.953 -173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.59 -171.49 18.99 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.44 132.29 32.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -110.12 136.94 48.56 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 176.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.75 129.77 18.46 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -163.94 159.33 20.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.729 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -93.14 130.18 42.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.393 0.616 . . . . 0.0 110.067 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -104.92 112.21 25.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.056 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -104.57 120.13 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.701 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.91 129.47 56.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.989 0.423 . . . . 0.0 110.804 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -56.79 129.89 77.78 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.521 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.44 142.27 26.38 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.786 2.324 . . . . 0.0 112.183 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.43 173.19 13.48 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.867 2.378 . . . . 0.0 112.092 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 36.8 t -105.51 144.7 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.69 -12.71 55.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 10.8 pt-20 -55.52 -23.96 29.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 111.132 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.04 -31.58 23.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.234 0.54 . . . . 0.0 110.022 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.72 102.96 34.8 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.394 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 161.49 6.29 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.212 2.608 . . . . 0.0 112.748 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.85 -40.15 20.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 p -73.36 -7.86 53.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -106.45 -24.46 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -173.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.0 pt? -104.58 22.85 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.426 0.631 . . . . 0.0 110.566 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 116' ' ' GLU . 49.9 t -118.93 56.67 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 122.403 1.097 . . . . 0.0 109.107 173.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 p -147.92 175.42 10.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.584 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 47' ' ' SER . 25.2 m -80.58 119.64 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.324 171.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 ' OG1' HG23 ' A' ' 113' ' ' VAL . 41.5 p -108.98 177.6 4.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 72.9 t -129.33 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.139 0.495 . . . . 0.0 111.289 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.564 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 51.4 mt -109.34 135.27 48.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.363 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.3 mt -117.3 123.95 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.791 0.329 . . . . 0.0 110.452 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -101.4 117.7 35.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.7 m -119.96 135.06 55.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.703 0.287 . . . . 0.0 110.848 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 49.0 t -119.27 131.81 55.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -125.16 126.63 45.56 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.936 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 64.2 t80 -111.97 122.14 46.94 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 63.09 29.29 16.24 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.568 0.542 . . . . 0.0 110.398 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.25 4.88 89.16 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.625 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.48 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 19.6 mtp180 -102.94 116.96 33.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.778 0.323 . . . . 0.0 111.159 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.02 120.76 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.268 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' CD1' HG23 ' A' ' 107' ' ' VAL . 28.4 p90 -113.8 -22.46 10.17 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 106' ' ' PHE . 10.5 t -133.09 119.92 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.472 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.3 ptp180 -131.08 117.66 19.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.254 170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 146' ' ' VAL . 1.7 t -108.97 120.25 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.272 -174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.07 143.95 15.8 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.744 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 46.9 m-85 -136.42 149.35 48.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.503 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 69.4 m-85 -99.66 139.51 35.21 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.498 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -122.34 127.28 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.807 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.3 t30 -80.1 113.23 18.12 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.63 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.9 m120 -111.07 120.13 41.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.555 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.4 pt-20 -160.3 169.58 22.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.264 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.418 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 53.4 m-85 -81.56 124.38 29.46 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' HG23 ' A' ' 136' ' ' VAL . 15.7 t70 -52.22 -31.34 31.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.988 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -96.49 127.67 42.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.703 0.763 . . . . 0.0 111.361 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.96 -40.8 73.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.161 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -61.51 -31.97 71.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.04 0.448 . . . . 0.0 111.098 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.8 mt -77.76 -31.79 52.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.253 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -69.64 -36.23 75.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.12 -47.13 53.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.53 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -125.98 88.34 54.45 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.062 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.59 134.83 46.2 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.134 2.556 . . . . 0.0 112.707 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.5 155.89 62.56 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.848 2.366 . . . . 0.0 111.906 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -46.74 53.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.364 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -81.29 138.67 35.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.751 174.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 89' ' ' LEU . 8.0 p -77.72 123.01 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.832 0.825 . . . . 0.0 111.191 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 135' ' ' ILE . 27.7 mt-30 -103.55 77.89 1.54 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.898 173.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.4 t -65.18 -23.58 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.867 -171.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.06 -23.66 67.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.479 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -102.9 -1.79 28.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.977 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 130' ' ' VAL . 61.6 mt -92.02 127.27 44.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.411 0.624 . . . . 0.0 110.04 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.7 t -98.56 141.09 16.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.168 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -108.88 110.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.166 169.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 28.1 t30 -110.66 108.3 18.17 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 11' ' ' VAL . 8.9 mt -80.14 121.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.381 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -83.25 65.19 8.14 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.6 -4.69 28.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.337 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.21 -30.54 69.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 29.3 pttt -123.06 96.88 44.19 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 0.0 111.451 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.7 125.86 5.06 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.093 2.528 . . . . 0.0 111.821 170.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -105.86 102.02 11.48 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.103 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 109' ' ' VAL . 17.0 t -112.11 138.41 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 -168.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.9 m -124.44 123.73 40.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.938 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -104.82 131.52 52.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.126 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.59 158.19 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -100.7 120.24 39.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.326 0.584 . . . . 0.0 110.235 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 5.4 pt -124.69 162.72 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.517 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.31 114.85 29.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.665 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 95.3 m95 -85.9 131.78 34.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 31.98 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.572 1.795 . . . . 0.0 114.585 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -151.04 13.85 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.513 -0.117 . . . . 0.0 110.74 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 37.5 tt0 -63.64 112.2 2.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -173.84 -76.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.119 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 50.9 38.19 19.38 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.113 0.482 . . . . 0.0 111.436 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -131.33 -42.3 0.2 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -81.16 88.26 6.02 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.37 -32.29 71.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.985 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.46 110.34 28.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.476 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 138.98 71.75 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.145 2.564 . . . . 0.0 112.915 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.32 117.24 4.19 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.855 2.37 . . . . 0.0 111.71 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.14 128.28 34.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.019 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 166' ' ' GLN . 1.9 mp0 -71.58 134.7 84.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.932 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 17.3 Cg_exo -66.41 81.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.033 2.488 . . . . 0.0 112.383 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.39 52.68 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.99 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.83 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 121.134 0.492 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -105.68 138.24 42.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.475 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.568 HG22 ' H ' ' B' ' 422' ' ' THR . 1.3 mt 55.67 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.568 ' H ' HG22 ' B' ' 421' ' ' ILE . 75.6 m -149.02 98.34 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 168.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . 0.497 ' HE1' ' O ' ' A' ' 71' ' ' LYS . 31.6 mmt -80.9 91.01 5.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.491 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -76.7 158.47 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.23 176.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -111.41 94.23 21.77 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.475 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 83.3 Cg_endo -76.72 80.06 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.358 2.039 . . . . 0.0 112.326 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -54.54 135.64 45.8 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.614 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.56 136.8 58.16 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' B' ' 429' ' ' LYS . 1.0 OUTLIER -67.6 103.33 1.34 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.505 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.04 37.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.195 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -62.75 -50.4 71.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.387 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 52.95 49.07 21.0 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.212 0.529 . . . . 0.0 111.169 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.953 179.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -137.53 66.64 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.38 67.43 4.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.763 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 75.05 -84.28 0.82 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 153' ' ' TRP . 35.8 m -94.22 126.23 39.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 153' ' ' TRP . 42.0 mm -68.25 -21.15 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.563 0.697 . . . . 0.0 109.998 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.577 HG13 ' CD1' ' A' ' 28' ' ' PHE . 84.2 t -128.66 116.56 41.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.581 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.8 t -124.06 137.95 54.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.491 HD13 ' CH2' ' A' ' 40' ' ' TRP . 27.9 tp -86.59 115.14 23.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.6 mp -74.78 -32.37 62.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.22 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.86 175.62 36.49 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.231 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 109' ' ' VAL . 14.8 mt -132.27 143.47 39.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.641 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 56.2 tptt -108.93 111.53 23.27 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.608 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 HD12 ' A' ' 139' ' ' ILE . 64.8 t -67.73 98.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.986 166.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -66.11 -47.16 75.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.224 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.23 110.51 21.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.473 -172.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 9.7 t-20 -165.61 110.01 0.76 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.305 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 3.4 Cg_exo -77.38 150.29 90.84 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 124.327 -1.114 . . . . 0.0 111.894 -1.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.1 178.05 4.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.458 0.647 . . . . 0.0 111.136 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.65 135.48 53.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 79' ' ' PRO . 45.8 t80 -63.71 -26.69 68.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.47 14.21 25.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.939 0.4 . . . . 0.0 111.501 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.31 134.43 22.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.63 130.77 40.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 113.3 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -86.18 145.84 26.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.139 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 37.9 mt-10 -129.55 124.51 34.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.27 0.557 . . . . 0.0 110.488 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 60.3 m-85 -123.31 135.4 54.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.821 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 34.8 tt0 -95.86 117.44 30.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.544 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 21.8 mm -88.7 128.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.771 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -131.34 117.43 18.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.551 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.587 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.6 p90 -138.56 160.71 38.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.329 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' A' ' 7' ' ' LEU . 7.0 tp10 -103.47 118.55 37.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.815 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 43.2 t -89.33 106.46 18.46 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.72 -26.88 40.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.1 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -148.7 146.04 27.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.796 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -64.86 124.11 21.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.232 0.539 . . . . 0.0 111.428 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD23 HG22 ' A' ' 65' ' ' VAL . 2.9 mm? -74.91 117.15 16.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.592 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.697 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -80.72 -26.45 37.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.211 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 28.4 m-70 -98.07 165.83 11.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 61' ' ' LEU . 26.2 m-20 -86.86 144.83 26.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.132 0.492 . . . . 0.0 112.27 -170.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 62' ' ' VAL . 81.4 mt -99.92 128.23 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.233 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 36.8 tt0 -117.71 116.12 26.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.409 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 89.5 m95 -105.26 135.54 46.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -147.93 157.99 43.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.948 0.404 . . . . 0.0 111.851 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tp -114.99 132.3 56.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 94.2 m -120.79 136.04 55.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' HB3' ' HG3' ' A' ' 55' ' ' GLN . 77.4 t80 -95.46 132.34 40.64 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.82 122.76 65.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 49' ' ' ARG . . . -69.86 81.9 0.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.264 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m 65.2 -86.04 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 111.304 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 m -152.72 -20.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.859 0.361 . . . . 0.0 110.615 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -80.73 -26.57 37.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.083 178.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m 53.25 74.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.909 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.2 mt -73.87 -15.78 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.612 0.72 . . . . 0.0 109.65 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.68 -10.64 47.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.926 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 66.95 29.52 8.1 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.712 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 104.57 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.797 0.686 . . . . 0.0 110.091 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG3' ' HB3' ' A' ' 44' ' ' TYR . 16.9 pt20 -113.06 118.16 34.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.461 0.648 . . . . 0.0 111.423 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.47 117.97 14.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.722 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.2 mm? -75.25 -60.82 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.51 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -158.09 168.87 25.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 p -142.13 145.26 34.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 111.217 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 29.7 pt -118.25 151.54 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.591 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.4 tm? -121.08 136.74 54.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.852 0.358 . . . . 0.0 110.441 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -137.7 136.92 45.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.325 . . . . 0.0 111.395 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.43 153.24 5.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 173.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.09 124.27 8.7 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 123.675 -1.385 . . . . 0.0 111.365 -6.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.839 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -88.9 129.92 46.66 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.205 0.526 . . . . 0.0 110.74 -174.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' B' ' 422' ' ' THR . 36.3 Cg_exo -59.83 151.84 68.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.711 2.941 . . . . 0.0 113.743 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 15.4 t -70.19 139.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.71 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.01 -169.71 18.89 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -82.91 133.46 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 118.428 1.114 . . . . 0.0 108.215 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.536 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.2 m-80 -111.39 136.69 50.16 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.0 ttmt -145.43 134.15 22.27 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -169.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.57 161.71 16.15 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.543 0.527 . . . . 0.0 109.736 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.18 132.74 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.472 0.653 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 9.0 t80 -108.05 107.86 18.71 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.067 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -104.02 120.95 42.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.81 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.28 132.37 54.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.816 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 4.2 m-20 -63.58 139.3 97.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.543 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.23 149.41 17.16 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.042 2.495 . . . . 0.0 113.013 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 56.0 Cg_endo -73.78 134.02 19.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 112.061 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 140.33 54.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.45 -15.55 60.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.438 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.19 -21.45 33.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.95 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 55' ' ' GLN . 5.7 mt -82.21 -31.95 30.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 110.32 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -125.18 102.4 30.74 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -49.0 161.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.501 2.801 . . . . 0.0 113.266 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -47.74 -41.95 24.22 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -78.49 -13.41 59.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -96.41 -24.54 16.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 115' ' ' ASN . 2.1 pt? -96.97 5.08 51.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.918 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 116' ' ' GLU . 43.2 t -96.72 58.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.004 0.907 . . . . 0.0 109.598 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 36.7 m -148.13 169.67 19.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.279 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.87 139.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 109.411 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 p -134.63 179.04 6.54 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.241 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.5 t -128.03 134.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.01 0.433 . . . . 0.0 110.494 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.625 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 90.0 mt -105.07 135.46 43.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.551 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 96.7 mt -114.93 116.92 29.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.951 0.405 . . . . 0.0 110.759 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 3.4 tt -96.47 116.57 29.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 14.1 m -129.44 147.13 51.23 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.755 -170.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.582 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 44.9 t -131.76 137.55 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.536 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 62.6 m -118.42 138.51 52.41 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.258 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 34' ' ' LEU . 82.4 t80 -110.0 107.25 17.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 61.38 29.58 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.142 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.04 68.7 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.127 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.41 ' HD2' ' OE2' ' A' ' 156' ' ' GLU . 38.9 mtp180 -99.15 114.81 27.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.332 0.566 . . . . 0.0 110.804 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.79 120.32 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 151' ' ' ILE . 22.3 p90 -111.69 -21.95 11.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' SER . 3.9 t -138.39 119.99 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HD2' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -132.17 116.46 17.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -109.58 122.98 65.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.308 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -103.4 144.75 16.03 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.847 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -133.62 140.72 47.28 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.561 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 45.6 m-85 -87.23 136.12 33.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -128.02 133.62 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.569 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 138' ' ' ASN . 3.1 p-10 -95.63 130.37 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 18.3 t30 -122.73 124.09 42.59 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 90' ' ' VAL . 10.3 pt-20 -156.44 165.02 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.81 111.66 20.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.99 -5.74 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.6 0.714 . . . . 0.0 109.768 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' CG ' ' HB3' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -94.99 107.88 19.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -37.68 74.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.304 -169.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.95 -34.93 79.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.12 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.2 mt -83.77 -26.59 29.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -70.31 -46.81 63.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.625 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.492 ' C ' HD22 ' A' ' 125' ' ' ASN . 49.0 mt-10 -67.99 -47.04 69.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.492 HD22 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -117.31 87.24 23.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.985 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.73 127.09 19.68 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.818 2.346 . . . . 0.0 111.916 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.94 167.28 27.74 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.494 2.13 . . . . 0.0 111.756 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.66 -35.91 44.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.163 0.506 . . . . 0.0 109.978 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 9.1 mptt -86.81 120.33 27.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.177 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 135' ' ' ILE . 7.4 p -75.92 124.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.546 0.688 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -105.36 77.66 1.31 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 81' ' ' ALA . 4.6 t -63.82 -22.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.222 -171.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.92 -25.1 67.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 0.0 110.793 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.456 ' HB3' ' CG ' ' A' ' 119' ' ' GLU . 42.8 m-70 -102.99 -3.28 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 110.139 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 130' ' ' VAL . 53.5 mt -87.2 129.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.432 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 42.4 t -98.51 131.29 45.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.414 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 113' ' ' VAL . 4.4 tpp180 -109.2 108.9 19.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.659 ' HB3' ' OD1' ' A' ' 114' ' ' ASN . 7.7 t30 -114.15 125.47 53.98 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.548 HD12 HG13 ' A' ' 11' ' ' VAL . 2.9 mt -91.35 119.65 38.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.052 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 140' ' ' LEU . 2.0 mm? -78.2 73.66 4.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.2 -4.69 26.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.011 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.6 pt-20 -59.65 -30.85 69.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.791 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 35.1 pttt -123.66 97.16 42.24 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.835 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.47 133.27 7.17 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.14 2.56 . . . . 0.0 111.517 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 33.5 mtp180 -107.83 101.63 10.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 109' ' ' VAL . 16.5 t -102.97 128.15 56.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -173.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 49.7 m -123.88 127.43 48.0 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 148' ' ' ARG . 33.7 mmm-85 -110.23 134.46 52.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -111.68 142.46 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -84.03 102.03 12.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.567 0.698 . . . . 0.0 110.486 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 106' ' ' PHE . 4.9 pt -116.52 163.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.272 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.1 126.37 46.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.926 0.393 . . . . 0.0 110.737 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.565 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 74.8 m95 -110.27 141.59 43.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.623 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.33 -62.47 0.17 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.559 1.162 . . . . 0.0 112.562 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -86.42 25.87 1.15 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 104' ' ' ARG . 38.6 tt0 -79.52 97.57 6.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.153 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -121.56 117.47 26.84 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 175.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -86.88 -174.99 5.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.076 -174.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.11 -161.77 19.19 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 162' ' ' TYR . 28.8 t70 -88.4 51.41 2.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.489 0.661 . . . . 0.0 109.692 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.7 mt 66.23 -2.62 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.697 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 160' ' ' ASP . 85.6 m-85 -110.87 120.08 44.42 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HB3' ' OD1' ' A' ' 157' ' ' ASN . 22.7 Cg_endo -61.83 129.07 26.27 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.484 2.123 . . . . 0.0 113.074 -174.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -85.87 81.76 1.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.966 2.444 . . . . 0.0 110.428 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.05 111.48 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.841 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -83.04 147.38 54.02 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.776 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.26 74.7 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.606 2.204 . . . . 0.0 111.939 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.66 122.46 2.86 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.638 179.571 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -112.89 104.43 12.41 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.558 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 149.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.973 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.422 HG21 ' HD2' ' A' ' 66' ' ' PRO . 91.1 m -78.04 -35.44 49.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.868 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . 0.412 ' CE ' ' HB3' ' A' ' 71' ' ' LYS . 12.6 mmt 55.12 65.69 1.43 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.079 0.466 . . . . 0.0 110.312 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.536 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -66.78 165.16 15.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.511 -178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -117.1 92.84 40.69 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.515 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.1 Cg_endo -78.9 65.53 8.79 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.573 2.182 . . . . 0.0 112.539 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -63.57 146.82 52.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.879 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -62.81 165.91 6.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.658 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.76 18.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -168.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -84.61 39.43 0.74 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 111.183 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -91.95 -4.7 54.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.032 0.444 . . . . 0.0 110.383 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -98.84 150.94 21.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.361 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.207 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.309 -0.317 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -107.15 78.83 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.006 0.432 . . . . 0.0 110.97 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.35 56.14 3.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.393 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 77.9 -56.59 3.91 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.251 -0.5 . . . . 0.0 111.97 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -120.26 130.45 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.79 -21.48 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.592 0.711 . . . . 0.0 110.393 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 53.2 t -131.44 131.83 62.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.782 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 20.9 t -139.3 140.33 37.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 HD13 ' CH2' ' A' ' 40' ' ' TRP . 28.3 tp -86.9 115.87 24.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.072 0.463 . . . . 0.0 109.965 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.5 mp -74.69 -33.45 62.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.312 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.74 172.18 29.89 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.369 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 109' ' ' VAL . 8.0 mt -127.44 143.61 40.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 51.6 tptt -104.28 112.79 25.96 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.571 -0.451 . . . . 0.0 109.815 173.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG11 ' HB ' ' A' ' 139' ' ' ILE . 39.1 t -71.44 102.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 169.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.8 mm? -69.05 -46.99 66.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.704 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -82.95 105.73 14.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.1 m-20 -163.69 108.45 0.95 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 123.616 0.572 . . . . 0.0 110.621 172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 68.2 Cg_endo -87.1 173.85 31.22 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 124.607 -0.997 . . . . 0.0 112.267 -3.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.04 -179.34 7.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -90.78 171.3 9.43 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.497 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 85.8 t80 -72.58 -33.83 67.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.893 0.378 . . . . 0.0 110.05 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -85.49 13.78 6.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.6 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.29 153.65 46.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.955 175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.9 Cg_endo -56.51 134.81 66.68 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.951 2.434 . . . . 0.0 112.346 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' SER . 48.8 m-85 -85.38 115.24 23.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.671 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 41.6 mt-10 -122.72 116.3 23.53 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.317 0.58 . . . . 0.0 110.537 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 66.2 m-85 -127.77 135.33 49.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.859 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.9 tt0 -101.8 120.15 39.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.693 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.733 HD11 HD11 ' A' ' 97' ' ' LEU . 22.2 mm -89.34 131.25 37.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.416 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -130.92 116.83 18.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.273 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HA ' HD13 ' A' ' 7' ' ' LEU . 51.4 p90 -137.61 159.46 41.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 7' ' ' LEU . 31.8 tt0 -105.59 120.59 42.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.448 0.642 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 35.7 t -89.38 112.18 23.22 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.954 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.37 -29.65 37.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -150.33 144.33 25.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -59.76 124.05 18.9 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.083 0.468 . . . . 0.0 111.216 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 65' ' ' VAL . 2.8 mm? -78.47 100.32 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.154 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -72.62 -18.17 61.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.195 173.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.618 ' HB2' ' CE2' ' A' ' 101' ' ' TYR . 62.1 m-70 -96.13 164.75 12.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.638 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.6 p-10 -92.35 145.67 24.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.341 0.591 . . . . 0.0 112.489 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.749 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.8 mt -107.89 121.31 44.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.78 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.37 123.32 48.18 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 90.6 m95 -107.62 135.73 48.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' OE1' ' A' ' 56' ' ' GLU . 3.8 ptpp? -147.58 156.49 42.87 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.038 -173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.3 tp -117.05 130.24 56.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 86.6 m -115.7 133.15 56.32 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB2' HD21 ' A' ' 57' ' ' LEU . 54.0 t80 -94.65 129.49 41.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.8 126.85 74.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.348 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' O ' ' HD3' ' A' ' 49' ' ' ARG . . . -69.83 86.47 0.29 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.616 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 m 47.93 -102.47 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.826 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 p -138.78 21.14 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.498 . . . . 0.0 110.609 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.739 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -112.74 -32.73 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.955 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m 44.96 56.78 5.1 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.556 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.14 -18.83 61.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.629 0.728 . . . . 0.0 109.669 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.77 -5.55 57.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.701 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 66.6 16.1 10.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.225 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 67.55 147.97 0.05 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.707 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 pm0 -144.6 130.07 18.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.68 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 30.1 tt0 -79.02 121.69 25.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.338 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.8 mm? -74.17 -60.38 2.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.01 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.99 167.99 27.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.65 138.53 30.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.193 0.52 . . . . 0.0 111.371 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 34.0 pt -116.51 155.62 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 37' ' ' ASP . 3.3 tm? -124.57 137.27 54.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -136.3 134.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 111.316 177.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.15 151.93 5.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 55.4 Cg_endo -70.82 126.31 10.22 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.245 -1.564 . . . . 0.0 112.006 -5.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -94.23 144.55 28.22 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-O 120.717 0.294 . . . . 0.0 110.406 -175.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.37 160.75 15.02 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.27 2.646 . . . . 0.0 113.391 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 20.4 t -70.76 147.07 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.162 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 119.67 -162.35 13.92 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.4 OUTLIER -85.2 134.67 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 118.218 1.009 . . . . 0.0 108.531 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -111.29 136.78 49.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.8 ttmt -148.13 132.86 17.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -168.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -165.0 157.49 15.98 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.646 0.591 . . . . 0.0 109.666 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.82 131.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.283 0.563 . . . . 0.0 109.829 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.5 t80 -110.16 116.01 30.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.28 -176.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 5.1 p -112.31 122.74 48.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.37 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.45 131.69 53.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.057 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 31.5 t70 -71.12 130.84 87.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.392 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 34.2 Cg_endo -62.46 149.98 89.02 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.722 2.948 . . . . 0.0 113.231 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.01 131.8 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.629 2.219 . . . . 0.0 111.94 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -57.87 132.57 53.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.023 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -61.83 -13.56 25.25 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.17 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -55.05 -21.84 13.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.702 0.287 . . . . 0.0 111.22 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.66 -31.83 41.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.87 102.3 35.07 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.258 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.01 160.09 2.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.069 2.513 . . . . 0.0 112.871 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -48.27 -44.87 33.94 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.6 t -73.96 -15.25 61.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.908 0.385 . . . . 0.0 111.283 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.61 -23.84 18.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.2 pt? -102.17 12.37 36.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.539 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 86' ' ' ALA . 61.4 t -100.75 57.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.152 0.977 . . . . 0.0 108.794 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 m -148.83 174.74 11.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.872 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 17.2 m -79.96 121.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.502 0.668 . . . . 0.0 109.602 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.5 p -108.65 177.83 4.66 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.892 -176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 86.6 t -128.37 130.67 69.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.243 0.544 . . . . 0.0 111.217 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.626 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 58.3 mt -105.35 135.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.771 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 98.0 mt -117.43 117.99 30.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD11 HD11 ' A' ' 26' ' ' ILE . 1.9 tt -96.92 116.04 28.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.7 m -125.35 134.75 52.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.201 0.524 . . . . 0.0 111.993 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 46.4 t -112.81 138.34 49.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.61 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.7 m -127.0 131.34 51.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.84 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' CE2' HD12 ' A' ' 34' ' ' LEU . 62.5 t80 -110.66 104.62 13.32 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.89 37.51 28.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.308 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.12 59.11 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.956 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 151' ' ' ILE . 10.8 mmm180 -78.88 114.76 18.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.84 0.32 . . . . 0.0 110.159 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.45 117.74 19.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.031 0.443 . . . . 0.0 109.903 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 79.3 t80 -106.61 -36.04 6.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.051 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.3 t -141.42 126.26 17.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.055 0.455 . . . . 0.0 111.154 -170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -133.73 119.37 19.22 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.697 171.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -109.58 117.48 54.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.264 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -98.08 143.47 16.7 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.642 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 69.0 m-85 -137.29 146.17 44.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.408 ' HB2' ' CE ' ' A' ' 143' ' ' LYS . 35.8 m-85 -90.58 137.63 32.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -120.25 128.15 75.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.35 178.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 3.4 t30 -83.99 111.66 19.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 16.9 m120 -114.81 120.48 40.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.777 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.464 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.1 pt-20 -154.81 166.18 34.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.622 -174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -83.9 112.29 20.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 136' ' ' VAL . 24.3 t70 -55.38 -34.85 64.7 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.0 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -95.47 127.61 41.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.348 0.594 . . . . 0.0 110.76 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 123' ' ' ARG . 6.7 tp10 -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.902 -169.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.14 -38.48 89.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.926 0.393 . . . . 0.0 110.65 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 69.2 mt -82.89 -30.53 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.475 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 120' ' ' GLU . 42.0 ttp180 -73.5 -36.17 65.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.34 -32.0 48.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.055 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -128.27 80.45 72.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.393 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.09 124.12 12.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.486 2.124 . . . . 0.0 112.003 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.71 172.95 11.75 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.747 2.298 . . . . 0.0 112.125 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.74 -37.09 56.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.292 0.568 . . . . 0.0 109.765 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.27 126.01 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.482 ' CG2' HD21 ' A' ' 89' ' ' LEU . 7.6 p -77.5 125.03 36.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.608 0.718 . . . . 0.0 111.469 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.29 75.86 1.39 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.775 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.2 t -64.73 -23.17 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 0.0 111.05 -171.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -69.66 -4.08 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.031 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -119.76 1.61 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.728 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 130' ' ' VAL . 62.8 mt -94.9 130.19 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.5 t -97.44 133.07 40.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.911 -172.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -107.78 112.21 24.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.382 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 114' ' ' ASN . 41.9 t30 -115.16 108.99 17.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.577 ' HB ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt -80.15 117.59 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.67 77.94 5.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.227 0.537 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.71 -8.15 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.482 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.559 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 7.9 pt-20 -58.67 -29.38 66.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.881 173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 5.8 pttm -126.15 95.98 37.9 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-O 121.169 0.509 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -82.71 126.1 4.5 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.062 2.508 . . . . 0.0 111.286 170.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -112.41 101.2 9.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 109' ' ' VAL . 21.2 t -101.91 130.82 51.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 -172.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 108' ' ' ARG . 5.3 m -125.83 122.86 37.34 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -128.05 143.12 51.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -115.81 145.88 42.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.0 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.88 108.84 9.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.46 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 106' ' ' PHE . 10.3 pt -117.7 172.83 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.667 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.65 119.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.673 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 91.3 m95 -102.75 142.71 33.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.371 -176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.11 -66.06 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.563 1.164 . . . . 0.0 113.357 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -86.69 18.22 3.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.763 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 104' ' ' ARG . 43.2 tt0 -65.83 133.9 51.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.39 133.0 42.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.329 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -89.99 157.45 17.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.74 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.29 117.85 10.07 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.947 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 67.39 48.08 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.347 0.659 . . . . 0.0 112.312 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.6 mt -88.09 -36.17 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.028 0.442 . . . . 0.0 110.07 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -115.01 92.73 32.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.034 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.61 130.91 39.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.593 2.195 . . . . 0.0 111.93 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.63 99.55 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.788 2.325 . . . . 0.0 111.733 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.94 144.52 56.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.956 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 167' ' ' PRO . 12.3 mm-40 -86.11 129.48 53.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.978 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 166' ' ' GLN . 24.6 Cg_exo -62.86 102.87 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.678 2.252 . . . . 0.0 111.78 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.25 92.38 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.056 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 119.529 -0.272 . . . . 0.0 110.86 -179.616 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 54.2 tp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . 61.88 -171.2 0.16 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.711 0.632 . . . . 0.0 111.288 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.518 HG23 ' CG1' ' A' ' 69' ' ' VAL . 2.6 mt 53.43 -139.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.481 ' H ' HG22 ' B' ' 421' ' ' ILE . 62.0 m -141.41 -57.81 0.49 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 121.209 -0.196 . . . . 0.0 111.27 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER 52.88 70.34 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.598 0.713 . . . . 0.0 109.75 -174.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.33 -35.33 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.678 -172.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' B' ' 427' ' ' ARG . 31.6 mmtm 67.05 84.04 0.17 Allowed Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -171.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.527 ' HB3' HG13 ' A' ' 62' ' ' VAL . 88.8 Cg_endo -79.6 -19.09 10.28 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.189 2.593 . . . . 0.0 115.079 -168.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' B' ' 425' ' ' LYS . 0.0 OUTLIER 52.56 -145.84 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -106.54 -171.33 1.87 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 15.3 ptmt -81.69 66.78 7.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.697 0.761 . . . . 0.0 111.564 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -126.91 62.49 1.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.297 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -86.24 94.56 9.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.408 0.623 . . . . 0.0 110.555 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -87.92 54.7 3.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.649 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.296 179.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -162.12 126.95 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.3 tpp -122.49 56.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 78.38 -59.84 4.01 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . 3.5 p -102.92 139.69 38.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 -21.54 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.24 0.543 . . . . 0.0 110.642 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 38' ' ' LEU . 43.3 t -125.02 116.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.079 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -116.71 128.8 55.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.558 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD13 ' CH2' ' A' ' 40' ' ' TRP . 37.5 tp -87.61 118.13 26.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -74.4 -34.23 63.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.929 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.92 -179.8 36.16 Favored Glycine 0 N--CA 1.434 -1.468 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.081 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 24' ' ' PHE . 5.4 mt -131.7 143.6 39.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 52.0 tptt -106.45 114.08 27.98 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.998 174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG13 HD12 ' A' ' 139' ' ' ILE . 92.7 t -72.05 101.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.3 mm? -62.31 -43.17 99.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -112.99 125.44 54.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 18.2 m-20 -160.1 125.56 2.28 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.147 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 83.5 Cg_endo -86.79 147.82 36.01 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 124.193 -1.169 . . . . 0.0 112.084 -5.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.47 -176.54 3.4 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 136' ' ' VAL . 8.9 mmmm -97.18 164.64 12.41 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.588 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.9 t80 -66.64 -39.67 88.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.87 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.483 HG23 HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -82.22 13.73 3.32 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 111.468 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 23.9 t70 -97.65 131.39 27.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 50.8 Cg_exo -53.8 128.2 28.64 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.309 2.673 . . . . 0.0 113.456 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 75' ' ' SER . 90.2 m-85 -71.34 129.84 39.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.847 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.93 119.53 31.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.124 0.488 . . . . 0.0 110.533 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 94.5 m-85 -124.84 135.37 52.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.477 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 32.8 tt0 -97.37 118.41 33.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.701 HD11 HD11 ' A' ' 97' ' ' LEU . 17.9 mm -89.95 126.1 42.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.05 0.452 . . . . 0.0 111.003 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -131.32 116.5 17.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.6 p90 -138.66 159.03 43.1 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 7' ' ' LEU . 39.3 tt0 -103.94 117.33 34.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.934 -176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 19.8 t -89.03 110.08 20.83 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.168 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.2 -33.04 56.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 0.0 110.356 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -143.92 142.63 30.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 p -57.54 120.03 7.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -78.17 101.4 7.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.195 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.699 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -71.95 -21.96 61.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.193 175.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 50.5 m-70 -96.23 152.57 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB3' HD21 ' A' ' 61' ' ' LEU . 46.8 m-20 -79.07 148.06 32.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.809 -172.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 62' ' ' VAL . 73.2 mt -99.69 126.36 45.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.029 172.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -112.22 115.38 28.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.543 ' CH2' HD13 ' A' ' 6' ' ' LEU . 83.3 m95 -104.19 127.8 51.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.526 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -140.26 158.48 43.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.942 0.401 . . . . 0.0 111.432 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 57' ' ' LEU . 4.1 tp -121.17 131.73 54.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.697 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.7 m -116.81 136.26 53.09 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 45.8 t80 -92.13 122.1 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG13 ' OG ' ' A' ' 50' ' ' SER . 4.1 t -121.63 144.37 31.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.082 0.468 . . . . 0.0 111.314 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' THR . . . -102.08 83.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.529 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m 66.79 -78.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.273 0.629 . . . . 0.0 111.223 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -153.31 -36.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.391 0.139 . . . . 0.0 110.989 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.512 ' HG2' ' N ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -67.52 -46.94 71.41 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.829 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.512 ' N ' ' HG2' ' A' ' 49' ' ' ARG . 19.4 m 49.02 72.5 0.29 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.33 -67.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 109.948 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -97.7 23.48 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 50' ' ' SER . 79.7 m80 -130.0 58.88 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.561 -171.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 4.0 p-10 -149.5 91.61 1.84 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.189 0.995 . . . . 0.0 110.067 167.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HD1' ' A' ' 44' ' ' TYR . 24.1 mp0 -129.0 120.93 26.9 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.86 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.01 116.47 5.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 42' ' ' LEU . 2.0 mm? -78.2 -35.58 48.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 -173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -178.04 177.61 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 15.8 t -163.09 134.2 4.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.236 0.541 . . . . 0.0 110.179 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 36.0 pt -115.22 146.14 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.8 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -120.73 133.08 55.36 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.758 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.26 134.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.18 -178.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.46 152.81 6.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.56 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.87 130.75 19.65 Favored 'Cis proline' 0 C--O 1.233 0.265 0 C-N-CA 123.255 -1.56 . . . . 0.0 111.488 -5.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -97.28 124.39 49.34 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.928 0.394 . . . . 0.0 110.086 -177.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.43 170.64 11.67 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.221 2.614 . . . . 0.0 113.764 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.461 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.9 t -69.06 149.18 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.635 -172.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.24 -165.14 12.23 Favored Glycine 0 N--CA 1.454 -0.155 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -90.3 133.49 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.381 1.09 . . . . 0.0 108.716 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 41.3 m-80 -111.47 137.3 49.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 20.9 ttmm -144.16 136.33 26.46 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -168.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.28 158.94 14.48 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.881 0.738 . . . . 0.0 109.508 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.23 129.57 43.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.62 0.724 . . . . 0.0 110.543 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -108.39 116.97 32.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.866 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 18.1 m -110.88 121.71 46.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.201 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 57' ' ' LEU . . . -116.34 139.63 50.2 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.235 0.54 . . . . 0.0 111.817 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.31 123.17 73.46 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.002 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.4 Cg_endo -66.01 156.08 66.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.122 2.548 . . . . 0.0 112.686 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -84.02 143.08 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.544 2.162 . . . . 0.0 111.512 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m -65.17 131.68 47.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -61.85 -14.82 37.03 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.815 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.7 -21.47 54.89 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.022 -0.424 . . . . 0.0 111.129 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 HE21 ' A' ' 55' ' ' GLN . 11.6 mt -82.93 -30.69 28.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.34 0.59 . . . . 0.0 109.771 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 2.1 pt -124.04 102.78 33.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.704 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 84' ' ' ILE . 14.0 Cg_endo -57.2 160.9 12.12 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.621 2.214 . . . . 0.0 112.191 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -47.58 -42.63 24.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.8 m -75.93 -3.77 37.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.36 -22.84 9.69 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 135' ' ' ILE . 2.1 pt? -92.42 -16.17 26.25 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.831 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 116' ' ' GLU . 98.8 t -86.87 65.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 122.173 0.987 . . . . 0.0 109.596 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -149.21 169.42 20.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.103 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 33.8 m -79.51 121.58 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 122.142 0.973 . . . . 0.0 109.332 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.476 HG21 ' OH ' ' A' ' 44' ' ' TYR . 9.6 p -116.71 178.12 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.831 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 89.2 t -128.55 135.26 62.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.094 0.473 . . . . 0.0 110.381 -174.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.653 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 73.4 mt -105.04 134.64 45.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.395 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.7 mt -115.65 116.01 27.37 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.631 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.29 115.62 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 4.5 m -122.36 135.18 54.66 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.726 0.298 . . . . 0.0 110.274 -170.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 43.0 t -114.89 130.63 56.94 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.848 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 19.4 m -115.42 131.37 56.95 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.641 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 71.6 t80 -109.66 110.5 21.56 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 59.96 34.66 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.041 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.74 11.38 65.85 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.706 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' SER . 22.0 mtp180 -117.89 118.45 32.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.356 0.578 . . . . 0.0 110.948 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 36.2 tt0 -76.21 120.06 20.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.732 0.301 . . . . 0.0 110.309 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 151' ' ' ILE . 33.2 p90 -116.92 -17.06 10.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 106' ' ' PHE . 8.9 t -135.48 119.67 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 4.7 ptp180 -130.21 120.94 25.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.38 0.609 . . . . 0.0 109.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.981 HG13 HG22 ' A' ' 146' ' ' VAL . 2.3 t -110.13 120.84 61.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.88 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -105.38 144.2 15.76 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.932 -176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 44.1 m-85 -137.71 148.29 45.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 24.1 m-85 -95.3 140.11 30.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG23 ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -119.73 127.56 75.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.2 0.524 . . . . 0.0 110.977 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -85.36 117.78 24.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.338 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 39.3 m-80 -117.84 126.26 52.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.996 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 90' ' ' VAL . 11.2 pt-20 -158.97 169.76 23.61 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.119 -173.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -91.49 124.97 36.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.317 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.98 -11.05 55.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 110.255 172.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 109.15 21.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 39.7 tt0 -54.97 -42.65 72.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.907 -174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.74 -33.44 72.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.238 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.51 -32.71 22.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.998 0.428 . . . . 0.0 110.077 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -63.8 -47.03 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 10.7 pt-20 -73.14 -39.28 65.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.824 0.345 . . . . 0.0 110.721 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -120.45 86.6 39.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.11 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.97 123.95 14.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.346 2.031 . . . . 0.0 111.562 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.13 172.09 16.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.484 2.122 . . . . 0.0 112.911 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.86 92.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.248 0.547 . . . . 0.0 110.296 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -101.36 131.73 47.29 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.356 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 135' ' ' ILE . 7.5 p -74.73 127.12 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.416 0.627 . . . . 0.0 110.797 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.53 78.5 1.21 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -64.07 -22.12 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.192 -171.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -63.37 -22.51 66.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 110.031 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -112.07 19.89 17.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.466 HD11 HG23 ' A' ' 130' ' ' VAL . 61.4 mt -104.37 129.33 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 55.2 t -97.54 129.45 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.817 -173.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -111.84 110.96 21.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -114.1 118.26 33.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.735 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 11' ' ' VAL . 4.1 mt -87.31 114.91 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.255 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 76.3 3.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 109.789 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.84 -5.66 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.77 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 10.4 pt-20 -59.75 -23.59 63.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.614 174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 32.3 pttt -133.26 96.62 17.14 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.27 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -82.03 125.8 4.83 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.01 2.473 . . . . 0.0 111.494 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -110.68 101.31 9.96 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.981 HG22 HG13 ' A' ' 109' ' ' VAL . 15.5 t -114.09 139.21 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.117 0.485 . . . . 0.0 111.578 -167.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.1 m -133.27 131.5 40.31 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.346 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -109.34 141.05 42.24 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HE2' ' OE2' ' A' ' 105' ' ' GLU . 23.2 m-85 -114.82 136.62 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.97 112.67 11.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.895 0.378 . . . . 0.0 110.562 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 106' ' ' PHE . 3.1 pt -116.82 159.44 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.1 111.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.403 ' NE1' ' HA ' ' A' ' 2' ' ' SER . 64.7 m95 -69.03 -167.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.771 -173.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -57.14 -8.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -78.08 -2.91 39.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.0 110.669 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.03 136.54 48.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -123.74 155.85 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -116.63 147.52 41.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.854 0.359 . . . . 0.0 110.942 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.03 -74.79 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.146 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.22 78.98 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 0.0 111.331 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 87.8 mt -100.68 13.58 34.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.369 0.604 . . . . 0.0 109.567 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -128.89 115.3 19.05 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.636 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 23.6 Cg_exo -66.06 154.8 72.58 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.82 2.346 . . . . 0.0 111.473 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 39.5 Cg_exo -61.08 93.9 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.016 2.477 . . . . 0.0 112.677 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -87.44 112.65 22.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.231 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -86.3 114.69 58.81 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.374 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.3 77.47 2.06 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.756 2.304 . . . . 0.0 111.843 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.41 48.09 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.744 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.614 -179.505 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -111.27 128.57 55.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.576 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.6 144.23 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.761 0.791 . . . . 0.0 111.898 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 51.7 m -83.47 -38.23 22.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.82 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 9.7 mmt 61.74 83.17 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -87.5 167.79 13.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.679 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.78 93.25 42.77 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.587 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 97.9 Cg_endo -78.76 141.27 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.513 2.142 . . . . 0.0 112.901 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.42 131.6 48.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.613 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.18 83.98 4.42 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.707 0.289 . . . . 0.0 110.345 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 34.19 66.73 0.25 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.567 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -106.09 31.38 5.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.241 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -102.57 -64.48 1.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.337 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 54.07 58.29 5.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.238 0.542 . . . . 0.0 110.848 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.347 -178.73 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -105.17 78.13 1.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.979 0.419 . . . . 0.0 111.195 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.17 71.72 10.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.428 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 72.87 -95.82 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.952 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 t -82.73 132.05 35.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.7 mm -86.6 -22.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.323 0.582 . . . . 0.0 110.611 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.654 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 78.0 t -128.67 136.14 60.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.143 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.4 t -147.19 136.15 22.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' A' ' 109' ' ' VAL . 27.0 tp -88.81 121.16 30.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 -174.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 28' ' ' PHE . 8.6 mp -75.28 -32.02 60.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.099 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 179.86 34.3 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.998 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 109' ' ' VAL . 5.5 mt -130.19 143.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 49.9 tptt -105.73 112.87 26.12 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.749 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 139' ' ' ILE . 54.2 t -71.23 98.39 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.272 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.7 mm? -65.59 -43.47 89.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.79 97.52 9.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 m-20 -159.11 110.98 1.56 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.58 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 95.7 Cg_endo -82.59 169.37 60.73 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 124.027 -1.239 . . . . 0.0 111.952 -2.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 177.76 11.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 22.3 mtmt -109.7 164.74 12.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 112.07 174.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 72.2 t80 -71.43 -27.04 63.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.191 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.71 6.49 34.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.51 . . . . 0.0 111.047 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -95.71 142.46 24.61 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.231 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.11 133.28 46.11 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.014 2.476 . . . . 0.0 112.392 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 75' ' ' SER . 59.2 m-85 -73.46 131.85 42.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.937 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.43 113.61 18.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.47 . . . . 0.0 110.956 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 82.2 m-85 -127.87 137.5 52.35 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.402 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 31.2 tt0 -97.86 117.35 32.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 97' ' ' LEU . 17.6 mm -89.32 127.43 42.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.147 0.499 . . . . 0.0 111.283 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 45.0 m -131.98 114.93 15.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.915 172.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' HD13 ' A' ' 7' ' ' LEU . 49.2 p90 -137.62 159.77 41.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.1 pt-20 -105.15 123.17 47.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.679 0.752 . . . . 0.0 109.989 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.8 t -94.04 104.49 16.53 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.491 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.56 -26.94 62.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.5 . . . . 0.0 110.319 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.19 148.41 25.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.218 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.528 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 20.0 t -67.3 117.34 9.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.709 0.29 . . . . 0.0 110.525 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 65' ' ' VAL . 3.2 mm? -60.79 122.62 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.648 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HE3' ' O ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -76.56 -19.04 58.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.127 176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 34.1 m170 -106.15 -162.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.835 174.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 61' ' ' LEU . 30.5 m-20 -110.05 151.65 26.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 111.643 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG23 ' A' ' 62' ' ' VAL . 64.0 mt -106.99 125.96 51.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.14 113.75 26.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.978 0.418 . . . . 0.0 110.098 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -109.2 135.26 50.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -147.85 161.78 40.58 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.285 -178.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp -113.31 133.48 55.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 97.1 m -119.56 131.77 55.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.739 0.304 . . . . 0.0 110.407 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' OH ' HG21 ' A' ' 93' ' ' THR . 47.0 t80 -95.89 127.13 41.64 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' OD1' ' A' ' 54' ' ' ASP . 67.3 t -116.58 111.14 34.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.137 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.94 100.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.316 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m 74.41 -71.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.586 0.755 . . . . 0.0 111.88 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.8 p -151.36 -54.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -96.93 -23.22 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.119 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.8 t 68.17 112.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.362 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.89 -16.58 63.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.613 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' CG ' HE21 ' A' ' 55' ' ' GLN . 3.7 m-20 -83.95 -2.52 56.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.243 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 64.19 38.86 7.92 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.729 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 45' ' ' VAL . 11.3 m-20 70.07 121.09 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.92 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.464 HE21 ' CG ' ' A' ' 52' ' ' ASP . 60.5 mt-30 -99.86 116.27 31.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -85.35 107.89 17.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 168.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 1.9 mm? -76.01 -61.54 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -151.96 162.63 40.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 13.0 p -146.2 150.8 36.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.135 0.493 . . . . 0.0 111.719 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 pt -117.67 156.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.125 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' ASP . 3.2 tm? -122.8 134.93 54.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -139.02 134.87 42.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.169 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.42 152.07 5.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.667 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.74 127.9 13.43 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 123.445 -1.481 . . . . 0.0 111.269 -5.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -92.37 132.23 32.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 19.0 Cg_exo -67.86 159.05 54.58 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.29 2.66 . . . . 0.0 113.682 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.36 148.93 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.813 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.77 -167.15 12.49 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' CG1' HG23 ' B' ' 421' ' ' ILE . 0.5 OUTLIER -85.54 137.41 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 118.353 1.077 . . . . 0.0 108.901 177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.5 ' OD1' HD23 ' B' ' 424' ' ' LEU . 42.7 m-80 -111.21 135.83 51.16 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 14.2 ttmm -143.9 129.01 18.67 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 26' ' ' ILE . 10.7 p90 -164.61 161.05 20.75 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.66 127.43 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.611 0.719 . . . . 0.0 109.687 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.67 121.34 45.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.821 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 23.1 t -116.48 130.76 56.94 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.81 138.22 51.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.475 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 19.9 m-20 -63.91 138.27 97.35 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.907 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.86 135.21 11.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.827 2.351 . . . . 0.0 112.57 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.2 161.53 40.48 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.774 2.316 . . . . 0.0 112.322 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.8 t -93.42 138.98 31.21 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.613 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -65.95 -12.62 56.21 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.624 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -54.72 -22.23 13.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.521 0.201 . . . . 0.0 111.297 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 7.1 mt -84.07 -30.91 25.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.131 0.491 . . . . 0.0 110.242 176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 101.97 36.3 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.232 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.53 160.34 5.33 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.075 2.517 . . . . 0.0 113.006 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.05 -46.86 33.86 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -72.95 -7.91 53.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -107.36 -25.25 11.53 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 86' ' ' ALA . 1.9 pt? -93.73 -26.23 17.09 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.451 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 116' ' ' GLU . 47.8 t -79.89 66.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.854 0.835 . . . . 0.0 110.079 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.8 t -148.97 176.94 10.0 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 m -79.2 116.16 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 122.107 0.956 . . . . 0.0 108.899 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.45 HG21 ' OH ' ' A' ' 44' ' ' TYR . 20.3 p -109.56 177.61 4.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.005 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.4 t -129.55 136.67 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.136 0.493 . . . . 0.0 110.623 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.617 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 61.4 mt -112.02 135.2 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.411 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 90.0 mt -117.66 123.62 46.57 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.958 0.409 . . . . 0.0 110.411 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 26' ' ' ILE . 1.5 tt -99.2 118.71 36.51 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 48.1 t -118.17 134.66 54.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.295 0.569 . . . . 0.0 111.576 -169.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.91 117.37 33.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.952 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -119.58 126.57 51.52 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.092 0.472 . . . . 0.0 110.522 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 57.0 t80 -114.43 114.27 25.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 58.94 35.53 24.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.1 -7.29 81.13 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.8 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.719 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 16.8 mtp180 -94.88 115.11 27.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 110.935 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.49 120.48 20.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.296 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.615 ' CD2' HG23 ' A' ' 107' ' ' VAL . 62.2 t80 -106.61 -32.68 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.654 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 106' ' ' PHE . 2.1 t -133.77 120.33 36.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.472 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.7 ptp180 -126.96 115.15 18.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 146' ' ' VAL . 2.0 t -103.73 116.4 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.62 142.9 15.87 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.848 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.82 147.23 46.44 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 32.9 m-85 -94.6 140.87 29.29 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -123.38 125.32 71.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.63 119.62 23.49 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.184 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 85.4 m-20 -112.81 123.73 50.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' HG13 ' A' ' 90' ' ' VAL . 16.8 pt-20 -156.24 166.96 31.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.951 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' HIS . 40.4 m-85 -91.6 123.3 34.91 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.79 -7.65 49.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.317 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -95.98 110.94 23.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -57.72 -35.54 70.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.607 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.416 ' HG3' ' HG ' ' A' ' 122' ' ' LEU . 11.3 pt-20 -58.79 -37.93 77.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.882 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 121' ' ' GLU . 95.7 mt -85.63 -28.71 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.061 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -66.58 -41.28 88.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.478 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.8 -37.82 34.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.761 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -120.68 80.2 31.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.3 124.19 13.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 111.919 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.67 160.27 50.19 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.611 2.208 . . . . 0.0 112.132 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.95 82.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -89.99 127.69 36.1 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG11 ' CB ' ' A' ' 81' ' ' ALA . 9.2 p -73.45 125.82 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.644 0.735 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -111.73 76.82 1.0 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 3.5 t -61.1 -20.51 22.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 -172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.85 -18.63 57.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.925 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 46.0 m-70 -119.31 16.74 13.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.206 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 57.2 mt -104.73 119.49 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 35.1 t -96.35 133.5 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -170.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.4 ttp85 -106.76 110.58 22.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -109.1 111.98 23.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.506 HG12 ' CG1' ' A' ' 113' ' ' VAL . 4.2 mt -84.75 115.94 27.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.28 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.1 77.55 6.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.08 -5.16 37.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.53 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.567 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.85 -29.21 66.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.011 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.567 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 36.0 pttt -129.5 96.65 26.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.182 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.01 125.81 4.85 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.866 2.377 . . . . 0.0 111.822 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -108.83 100.55 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 109' ' ' VAL . 11.6 t -118.22 139.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.199 0.523 . . . . 0.0 111.537 -167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 m -128.87 127.16 41.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.53 134.07 51.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.21 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.49 129.39 56.53 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.46 106.11 3.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 0.0 110.694 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 106' ' ' PHE . 8.8 pt -116.75 170.18 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.35 119.26 52.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.654 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 47.2 m95 -93.9 142.3 27.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 77.7 m-20 65.83 -40.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.605 1.191 . . . . 0.0 113.712 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -119.8 40.16 3.47 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.439 -0.163 . . . . 0.0 111.369 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.719 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 32.1 tt0 -63.25 116.61 5.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.35 125.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.085 0.865 . . . . 0.0 109.373 -170.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -81.28 69.4 7.89 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.336 0.588 . . . . 0.0 110.792 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.83 -46.64 5.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.256 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.68 120.97 31.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 80.8 mt -116.05 34.61 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.995 0.426 . . . . 0.0 110.09 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -117.56 100.78 52.7 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.721 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.89 135.89 64.58 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.495 2.13 . . . . 0.0 111.435 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.84 117.29 3.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.81 2.34 . . . . 0.0 112.067 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -70.58 97.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -101.76 125.36 37.4 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.325 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.4 75.63 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.564 2.176 . . . . 0.0 111.427 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -70.58 -33.51 67.36 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.194 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.673 179.288 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.274 0.559 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -110.4 101.52 10.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.327 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.678 ' HB ' ' SD ' ' B' ' 423' ' ' MET . 0.0 OUTLIER -107.16 148.37 11.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.911 -174.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 91.9 m -80.77 -47.89 13.27 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.448 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . 0.678 ' SD ' ' HB ' ' B' ' 421' ' ' ILE . 0.0 OUTLIER 54.19 73.84 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.558 0.694 . . . . 0.0 110.01 -168.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.5 HD23 ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -62.55 -37.13 84.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.483 -176.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 59.99 71.67 0.86 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 54.9 Cg_endo -65.25 141.08 67.35 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.035 2.49 . . . . 0.0 112.694 -169.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 13.1 ptm180 -92.26 172.36 8.46 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.522 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.55 160.99 15.14 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -81.04 45.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.743 0.782 . . . . 0.0 110.795 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -119.12 41.68 3.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.976 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -92.27 117.89 30.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.983 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 58.56 51.56 7.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.51 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.154 179.617 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . 73.62 85.54 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.552 0.692 . . . . 0.0 111.826 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 43.8 mtt -87.13 68.38 9.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.956 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 69.07 -110.41 3.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.515 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -72.0 116.19 12.11 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.7 mm -66.88 -25.58 34.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.003 0.43 . . . . 0.0 111.473 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 28' ' ' PHE . 59.0 t -128.67 116.85 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.218 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -119.19 135.36 54.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.575 HD13 ' CH2' ' A' ' 40' ' ' TRP . 33.3 tp -87.86 119.18 27.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.0 mp -74.58 -33.19 62.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.73 177.45 34.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.051 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD22 ' A' ' 97' ' ' LEU . 9.9 mt -128.09 144.74 36.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 48.8 tptt -110.86 113.27 25.72 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.986 172.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' A' ' 139' ' ' ILE . 71.0 t -69.46 100.78 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 168.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 10' ' ' LYS . 3.0 mm? -63.54 -33.54 75.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.611 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -125.76 112.2 15.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.785 0.802 . . . . 0.0 112.974 -170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 8.6 p30 -168.48 132.74 1.37 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.409 168.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.65 157.05 99.77 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 123.46 -1.475 . . . . 0.0 112.232 -2.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.95 10.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.001 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -85.6 139.5 31.37 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 24.5 t80 -61.86 -34.01 75.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.232 -175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.418 HG23 HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -90.02 14.53 12.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 111.765 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 21' ' ' PRO . 36.1 t70 -111.34 133.89 21.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.465 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 10.6 Cg_endo -54.43 141.43 72.64 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.452 2.768 . . . . 0.0 113.548 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 75' ' ' SER . 18.9 m-85 -94.91 144.82 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.473 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 45.8 mt-10 -129.96 123.12 29.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 63.0 m-85 -127.29 136.83 52.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.202 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 35.1 tt0 -97.92 117.29 31.92 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.54 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 97' ' ' LEU . 17.3 mm -89.08 128.02 41.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.235 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 m -132.28 116.63 17.15 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.899 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HA ' HD13 ' A' ' 7' ' ' LEU . 55.2 p90 -138.48 160.39 39.67 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.682 0.277 . . . . 0.0 110.486 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.57 120.36 41.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.441 0.639 . . . . 0.0 110.121 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 67' ' ' VAL . 42.8 t -89.65 113.13 24.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.875 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.84 -36.6 49.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.516 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.32 140.96 30.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -55.39 122.91 12.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.207 0.317 . . . . 0.0 110.819 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.818 HD23 HG22 ' A' ' 65' ' ' VAL . 3.1 mm? -67.24 112.78 4.69 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.701 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -73.67 -34.41 64.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.241 177.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 20.4 m-70 -101.39 151.53 21.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.167 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' HD21 ' A' ' 61' ' ' LEU . 4.4 m-20 -71.86 144.58 49.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.273 0.559 . . . . 0.0 112.402 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 62' ' ' VAL . 72.5 mt -98.76 136.73 38.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.19 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 24.0 tt0 -125.67 124.09 40.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.159 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.575 ' CH2' HD13 ' A' ' 6' ' ' LEU . 81.9 m95 -111.36 131.96 54.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -148.2 165.43 30.94 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.992 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.02 127.89 54.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.575 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 96' ' ' LEU . 38.2 m -109.49 130.82 55.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 42.1 t80 -86.97 116.02 24.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 98.7 t -117.11 144.74 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.014 0.435 . . . . 0.0 110.228 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HB3' ' A' ' 53' ' ' HIS . . . -115.37 112.96 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.992 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.2 m 61.98 -89.7 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 O-C-N 124.273 0.631 . . . . 0.0 111.368 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -160.51 -32.98 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.096 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -58.07 -42.36 85.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.555 0.217 . . . . 0.0 111.283 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.1 p 45.12 79.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.26 -52.88 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -100.85 13.4 35.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 48.8 m-70 -135.96 54.99 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.975 -172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 7.5 p-10 -149.05 93.97 2.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.973 0.892 . . . . 0.0 108.842 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -127.84 122.61 33.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.901 -170.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.67 109.81 16.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.81 -61.43 1.97 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.005 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.43 158.07 43.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.479 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 m -130.28 143.87 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.332 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 38.7 pt -115.17 141.45 31.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 37' ' ' ASP . 1.5 tm? -120.45 130.11 54.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.588 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.661 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -134.18 136.2 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 -175.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.32 152.85 6.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.526 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.73 126.9 13.32 Favored 'Cis proline' 0 C--O 1.234 0.313 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.369 -6.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.818 HG22 HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -91.95 139.04 24.46 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.164 -175.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 2.8 Cg_exo -76.93 160.89 33.54 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.223 2.615 . . . . 0.0 113.275 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' CYS . 22.0 t -70.31 141.84 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.334 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.61 -159.44 17.22 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.58 131.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 118.037 0.919 . . . . 0.0 108.779 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 46.8 m-80 -112.38 136.56 51.7 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 18.1 ttmm -145.04 136.96 25.68 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -165.21 159.32 17.36 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.005 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.31 128.91 44.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.487 0.66 . . . . 0.0 110.049 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 7.9 t80 -106.61 113.59 27.19 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.948 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 11.5 p -108.38 119.5 39.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.78 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.34 138.28 51.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.688 -178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 151.73 96.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.818 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.88 138.97 10.7 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.567 2.178 . . . . 0.0 112.828 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.81 126.48 19.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.993 2.462 . . . . 0.0 111.987 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 4.9 m -63.14 124.68 21.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.084 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -65.68 -15.62 62.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -56.7 -27.23 58.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.157 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -79.99 -29.12 39.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.094 0.473 . . . . 0.0 109.755 177.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.8 102.68 38.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.94 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.63 160.67 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.402 2.735 . . . . 0.0 112.823 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.29 -47.37 36.53 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -9.61 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' ' HE1' ' A' ' 53' ' ' HIS . 67.7 mm-40 -97.39 -26.04 15.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 ' CG2' ' A' ' 130' ' ' VAL . 2.1 pt? -105.09 -20.65 13.45 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 116' ' ' GLU . 44.7 t -82.69 60.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 122.272 1.034 . . . . 0.0 109.95 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.8 m -149.0 178.09 9.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.381 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 24.8 m -79.72 127.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.021 172.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.7 p -116.29 177.63 4.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.004 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.4 t -125.47 128.48 72.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.732 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 72.7 mt -105.01 133.76 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 81.2 mt -117.19 120.32 37.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.928 0.394 . . . . 0.0 110.742 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 26' ' ' ILE . 2.1 tt -100.35 116.6 32.7 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 8.1 p -125.39 139.05 54.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.125 0.488 . . . . 0.0 111.43 -172.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 49.9 t -116.76 133.79 55.58 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.111 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 59.8 p -119.5 137.42 53.81 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.582 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE1' HD12 ' A' ' 34' ' ' LEU . 38.4 t80 -111.13 116.66 31.49 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.76 29.56 19.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.721 . . . . 0.0 110.234 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.46 13.19 63.77 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.555 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 86.8 mtm-85 -119.67 122.26 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.494 0.647 . . . . 0.0 111.607 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE2' ' HE1' ' A' ' 149' ' ' PHE . 35.6 tt0 -79.2 120.49 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.046 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' HD13 ' A' ' 151' ' ' ILE . 26.0 p90 -114.69 -19.6 11.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 98' ' ' SER . 5.6 t -133.6 119.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.376 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 8.5 ptp180 -130.02 123.33 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.315 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.919 HG13 HG22 ' A' ' 146' ' ' VAL . 2.1 t -113.17 116.44 52.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.108 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.732 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -104.17 150.19 17.3 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.839 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 83.1 m-85 -138.14 140.45 39.89 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.431 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 23.4 m-85 -93.87 126.25 38.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 139' ' ' ILE . 17.4 m -129.9 141.67 45.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.421 0.629 . . . . 0.0 112.202 -168.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.87 116.31 25.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.014 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 32.6 m-20 -113.56 124.45 52.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HA ' HG13 ' A' ' 90' ' ' VAL . 21.0 pt-20 -157.59 165.17 36.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.724 0.297 . . . . 0.0 111.229 -173.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -83.44 121.24 26.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.99 -8.4 58.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.179 0.514 . . . . 0.0 110.878 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.8 mp0 -96.39 117.36 30.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.932 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 39.1 tt0 -58.57 -32.37 68.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.808 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.59 -39.15 79.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.915 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.01 -20.57 32.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 63.7 mtp85 -72.27 -39.39 68.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.521 . . . . 0.0 110.284 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -83.71 -29.82 27.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.788 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -121.99 76.32 39.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.798 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.34 123.81 9.44 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.6 2.2 . . . . 0.0 112.166 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.61 157.88 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.666 2.244 . . . . 0.0 111.774 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.91 -31.71 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.298 0.57 . . . . 0.0 109.86 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -88.47 135.38 33.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.499 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 81' ' ' ALA . 9.8 p -77.55 130.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.651 0.738 . . . . 0.0 112.369 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -112.52 78.21 1.11 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.674 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.492 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.8 t -63.54 -20.34 26.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.362 -170.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.5 -24.52 65.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.091 0.472 . . . . 0.0 110.067 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.55 0.63 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 130' ' ' VAL . 59.0 mt -93.17 128.42 44.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.572 0.701 . . . . 0.0 110.471 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 77.3 t -107.94 139.77 28.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.267 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.547 HH11 HG21 ' A' ' 113' ' ' VAL . 39.3 ttm-85 -111.1 112.21 23.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 170.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -101.76 111.96 24.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HA ' HG12 ' A' ' 113' ' ' VAL . 6.3 mt -82.71 116.76 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.447 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.0 mm? -82.5 80.74 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.678 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.32 -6.08 32.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.626 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 1.3 pt-20 -58.81 -28.24 65.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.445 175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 8.9 pttm -131.2 96.73 21.21 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.42 125.59 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.32 2.68 . . . . 0.0 111.88 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -103.78 100.3 10.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.919 HG22 HG13 ' A' ' 109' ' ' VAL . 12.0 t -113.02 135.96 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.302 0.573 . . . . 0.0 111.419 -169.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.0 m -128.94 126.5 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.465 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -108.17 133.69 52.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' HE1' ' OE2' ' A' ' 105' ' ' GLU . 34.1 m-85 -106.69 143.89 34.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.159 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -75.39 99.21 4.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.068 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 106' ' ' PHE . 35.5 pt -115.78 165.13 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 156' ' ' GLU . 24.1 t -106.31 136.32 41.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.168 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.53 -170.25 1.92 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.1 -12.76 54.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.262 0.553 . . . . 0.0 110.5 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -61.46 -49.05 78.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.004 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 37.5 tt0 54.97 64.82 1.68 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.776 -171.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 159' ' ' GLY . 2.2 t-20 -153.07 -16.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.241 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.2 pm0 -80.69 28.59 0.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.585 0.707 . . . . 0.0 110.413 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 157' ' ' ASN . . . -95.88 -37.32 4.99 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.106 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.83 45.89 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.358 0.599 . . . . 0.0 110.604 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 158' ' ' GLU . 60.0 mt -68.69 -37.67 79.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.067 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -121.09 86.26 42.26 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.449 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 Cg_exo -61.72 129.77 28.94 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.312 2.008 . . . . 0.0 111.232 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 35.3 Cg_exo -60.71 130.04 31.63 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.723 2.282 . . . . 0.0 112.441 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.62 147.97 37.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.762 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -111.31 134.71 21.06 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.129 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.25 60.09 3.9 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.559 2.173 . . . . 0.0 112.216 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -98.92 41.46 2.21 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.993 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.947 -179.443 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.643 0.259 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.36 112.75 20.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.927 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.35 147.02 19.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.307 0.575 . . . . 0.0 111.301 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.452 HG21 ' HD2' ' A' ' 66' ' ' PRO . 58.8 m -74.13 -41.02 62.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.287 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.7 mmt 55.08 72.9 0.44 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.487 0.66 . . . . 0.0 109.225 -171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -66.72 -39.91 88.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.903 -172.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 61.89 83.22 0.21 Allowed Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.479 ' HB3' HG13 ' A' ' 62' ' ' VAL . 74.5 Cg_endo -70.52 137.55 33.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.65 2.233 . . . . 0.0 112.5 -171.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.03 117.55 21.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.122 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -75.48 101.6 4.9 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 61' ' ' LEU . 10.8 ptpt -76.16 50.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.079 -175.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -117.18 31.25 6.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.933 0.397 . . . . 0.0 111.239 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.73 162.23 37.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . 56.34 36.84 28.17 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.603 0.565 . . . . 0.0 111.403 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.505 -0.76 . . . . 0.0 110.352 -178.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.43 78.87 1.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 110.978 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.75 58.17 4.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.958 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 81.35 -53.27 4.64 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -125.63 138.16 53.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.61 -23.52 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.218 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 24.7 t -135.39 130.97 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.641 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 32.8 t -136.19 143.73 44.56 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD13 ' CH2' ' A' ' 40' ' ' TRP . 29.7 tp -87.71 121.25 29.9 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 29' ' ' GLU . 6.7 mp -76.78 -33.11 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.263 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.4 178.21 36.07 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.215 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 109' ' ' VAL . 5.2 mt -129.25 145.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 66.8 tttt -111.82 111.27 22.11 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.072 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 139' ' ' ILE . 75.4 t -68.36 97.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -61.35 -49.08 78.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.98 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.07 108.19 20.3 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.543 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 8.6 t-20 -161.22 113.61 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 91.7 Cg_endo -86.01 162.85 56.68 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 124.25 -1.146 . . . . 0.0 112.591 -1.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.59 -176.22 4.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -101.76 157.21 17.0 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.659 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 65.6 t80 -62.4 -30.16 71.01 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.14 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.14 13.53 7.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -97.21 143.31 25.93 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.8 Cg_exo -61.73 125.99 17.95 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.547 2.165 . . . . 0.0 111.694 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' SER . 16.6 m-85 -78.23 134.71 37.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.184 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.85 116.5 22.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.222 0.534 . . . . 0.0 110.862 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 81.3 m-85 -121.94 135.56 54.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.304 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 42.7 tt0 -99.44 119.41 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 97' ' ' LEU . 20.4 mm -89.36 128.77 41.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.499 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.404 ' OG1' ' HE2' ' A' ' 71' ' ' LYS . 85.6 m -131.18 114.28 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.482 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 53.4 p90 -139.22 160.75 39.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' A' ' 7' ' ' LEU . 6.1 tp10 -104.45 122.04 44.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.929 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 t -91.87 116.33 28.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.937 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.31 -29.11 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.223 0.535 . . . . 0.0 110.593 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -147.89 143.24 27.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 20.2 t -56.44 117.23 3.63 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.392 0.433 . . . . 0.0 110.394 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 65' ' ' VAL . 3.5 mm? -66.94 123.88 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.802 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.62 -24.93 53.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.332 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.21 179.67 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.6 157.17 16.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.907 0.384 . . . . 0.0 111.328 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB2' HG23 ' A' ' 62' ' ' VAL . 45.7 mt -100.7 135.16 42.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.816 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.41 116.11 29.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.314 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.535 ' CH2' HD13 ' A' ' 6' ' ' LEU . 85.7 m95 -112.3 131.86 55.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HG2' ' CB ' ' A' ' 59' ' ' SER . 40.0 mtmt -139.99 153.04 46.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.542 -170.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 5.6 tp -117.81 128.4 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 m -116.46 131.41 56.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' OH ' HG21 ' A' ' 93' ' ' THR . 83.2 t80 -94.82 123.77 38.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG13 ' OG ' ' A' ' 50' ' ' SER . 67.2 t -120.33 134.4 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.103 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.12 86.8 1.43 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.4 m 62.08 -89.1 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.981 0.512 . . . . 0.0 110.197 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.511 ' H ' ' HD2' ' A' ' 49' ' ' ARG . 22.8 m -145.59 19.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.081 0.467 . . . . 0.0 109.88 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -121.27 -60.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.044 -176.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.484 ' OG ' HG13 ' A' ' 45' ' ' VAL . 13.3 m 67.74 100.2 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.817 0.698 . . . . 0.0 111.105 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.5 -34.58 72.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.885 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -84.69 12.27 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.693 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.6 m80 63.05 41.27 8.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 50' ' ' SER . 35.1 m-20 69.72 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.543 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 79' ' ' PRO . 66.0 mt-30 -108.43 115.94 31.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.19 105.33 17.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.05 -61.63 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.344 -171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.74 157.73 44.67 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.573 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 78.6 p -136.44 135.21 38.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.259 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 40.9 pt -115.55 150.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.517 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' B' ' 426' ' ' PRO . 5.6 tp -125.46 147.22 49.3 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.251 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.73 HG12 HD12 ' B' ' 424' ' ' LEU . 0.0 OUTLIER -134.66 134.21 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.191 0.52 . . . . 0.0 112.303 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.54 152.69 8.25 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.156 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.47 128.51 13.43 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 123.309 -1.538 . . . . 0.0 111.577 -4.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.51 110.57 57.3 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.203 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.78 173.64 5.09 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.76 2.974 . . . . 0.0 113.644 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 6.7 t -70.84 149.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.727 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.94 -169.58 12.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.9 OUTLIER -81.54 135.84 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -111.78 137.56 49.54 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 39.6 ttmt -144.5 132.37 21.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -171.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -163.53 160.74 23.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.753 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.33 129.52 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.668 0.746 . . . . 0.0 110.589 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 42' ' ' LEU . 6.3 t80 -107.13 117.08 33.12 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.721 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' TYR . 13.4 m -115.64 126.16 53.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.652 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.94 138.24 52.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -69.22 135.08 89.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.258 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 55.3 Cg_endo -69.26 152.0 71.89 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.714 2.276 . . . . 0.0 112.656 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . 5.2 Cg_exo -75.8 141.36 24.32 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.023 2.482 . . . . 0.0 111.668 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 m -68.24 125.6 26.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.971 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 132' ' ' VAL . . . -64.76 -16.21 62.68 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.819 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.7 -18.1 52.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.166 -0.333 . . . . 0.0 111.387 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.49 -30.0 33.48 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -124.38 101.66 34.1 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.319 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 160.74 4.88 Favored 'Trans proline' 0 N--CA 1.473 0.304 0 C-N-CA 123.147 2.565 . . . . 0.0 112.932 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . . . -48.1 -46.93 34.54 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -78.88 -1.21 34.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.31 -23.82 8.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 84' ' ' ILE . 1.9 pt? -86.35 -27.72 24.1 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.738 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.568 ' HA ' ' CG ' ' A' ' 115' ' ' ASN . 61.1 t -76.2 67.9 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.173 0.987 . . . . 0.0 110.627 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -148.87 176.44 10.4 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.476 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.59 136.92 22.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.199 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 112' ' ' TYR . 2.3 p -132.41 178.5 6.78 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.531 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 92.9 t -129.21 136.69 58.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 110.939 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.699 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 63.9 mt -110.58 136.56 46.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.334 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.59 121.1 39.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.983 0.421 . . . . 0.0 110.868 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 26' ' ' ILE . 1.1 tt -96.94 117.53 31.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.4 t -114.09 134.32 54.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.937 0.399 . . . . 0.0 110.961 -169.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 52.0 t -116.31 120.37 38.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.158 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -119.44 132.54 55.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.196 0.522 . . . . 0.0 111.378 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 34' ' ' LEU . 36.0 t80 -138.39 137.03 36.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.02 32.89 21.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 110.126 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.89 14.58 81.51 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.485 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.428 HH22 ' HB ' ' A' ' 152' ' ' VAL . 35.2 mtm180 -128.82 133.78 48.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.91 120.41 14.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.483 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB2' HD13 ' A' ' 151' ' ' ILE . 72.0 t80 -104.34 -34.13 8.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.417 0.627 . . . . 0.0 110.198 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.633 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.0 t -133.74 119.73 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.003 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 3.6 ptp180 -125.95 117.14 22.65 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 146' ' ' VAL . 1.6 t -108.11 116.75 52.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.904 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -101.24 141.98 15.55 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.784 -177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 31.1 m-85 -135.92 145.74 46.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' THR . 15.7 m-85 -93.25 136.62 33.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.438 ' HB ' ' CZ ' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -122.37 124.68 71.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.82 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -81.35 146.43 30.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.033 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.629 ' HB2' ' NH2' ' A' ' 137' ' ' ARG . 38.9 t-20 -130.58 130.33 43.9 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.9 169.73 24.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.553 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -96.14 123.41 39.75 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.85 -10.6 21.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.7 120.62 42.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.84 -31.88 73.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.189 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.36 -33.29 73.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.443 . . . . 0.0 110.806 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.41 -29.89 22.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.586 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -65.09 -46.88 79.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.18 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.56 -32.68 53.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 110.855 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -123.69 85.19 53.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.287 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.74 125.58 10.1 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.61 2.207 . . . . 0.0 112.511 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.13 168.49 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.51 2.14 . . . . 0.0 111.977 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -49.88 45.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 0.0 110.287 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -74.22 123.46 24.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.959 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.436 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -70.53 134.32 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.801 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.66 76.22 0.97 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.659 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -65.41 -19.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.697 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.28 -24.69 66.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.47 . . . . 0.0 110.693 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -112.41 21.68 15.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.56 HG23 ' OD1' ' A' ' 115' ' ' ASN . 12.8 mt -101.46 130.63 50.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.754 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 44.2 t -98.12 128.72 49.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.629 ' NH2' ' HB2' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -104.91 110.13 22.39 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.16 112.99 21.61 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.467 HD12 HG13 ' A' ' 11' ' ' VAL . 2.3 mt -83.45 118.91 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.399 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.98 71.65 6.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.54 -4.65 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.259 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 9.0 pt-20 -58.89 -27.5 65.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.065 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' HG3' ' A' ' 142' ' ' GLU . 35.2 pttt -130.59 96.9 22.53 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.052 0.453 . . . . 0.0 111.303 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.64 124.77 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.754 2.302 . . . . 0.0 111.34 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -101.69 100.15 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 109' ' ' VAL . 6.7 t -110.73 133.73 55.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.692 -171.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 108' ' ' ARG . 9.0 m -121.82 125.61 46.88 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -103.58 125.09 49.9 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.48 136.17 46.72 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.04 101.19 3.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.134 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' A' ' 106' ' ' PHE . 9.1 pt -117.13 156.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.428 ' HB ' HH22 ' A' ' 104' ' ' ARG . 23.0 t -94.92 112.3 27.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.855 0.36 . . . . 0.0 110.216 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.571 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 60.4 m95 -75.25 -172.61 1.77 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.578 176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 35' ' ' LYS . 19.0 t70 -75.4 73.33 2.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.692 0.758 . . . . 0.0 110.019 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -158.88 -118.67 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.169 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -165.79 59.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.069 0.461 . . . . 0.0 109.844 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -174.07 158.4 3.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.748 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.456 ' HG2' ' CE2' ' A' ' 162' ' ' TYR . 5.7 pt-20 -119.28 52.46 1.08 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.589 0.709 . . . . 0.0 109.96 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.59 49.33 1.11 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.227 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.6 38.89 29.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 111.475 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 158' ' ' GLU . 58.1 mt -105.34 1.3 27.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.422 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 158' ' ' GLU . 2.1 m-85 -120.53 89.64 44.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.763 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.76 133.15 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.21 1.94 . . . . 0.0 111.888 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.22 75.92 2.27 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.667 2.245 . . . . 0.0 111.94 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.62 144.2 56.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -89.12 115.98 65.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.211 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.07 143.39 84.38 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.723 2.282 . . . . 0.0 111.834 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.64 -117.23 4.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.795 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.692 -179.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 29.5 mt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.449 0.642 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . . . . . . . . . . . -146.33 120.12 9.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.491 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.413 ' HA ' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -77.29 159.64 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.593 0.711 . . . . 0.0 111.726 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 70' ' ' ASN . 63.3 m -127.35 107.37 9.92 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.53 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 32.8 mmt -79.94 90.19 5.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.214 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.73 HD12 HG12 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -77.58 164.0 25.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.335 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . 0.659 ' HD3' ' H ' ' B' ' 425' ' ' LYS . 0.2 OUTLIER -112.37 101.99 53.32 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 83.6 Cg_endo -82.34 83.54 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.06 1.84 . . . . 0.0 112.084 -176.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -63.21 131.99 50.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.735 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -84.01 92.34 7.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.206 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.05 -26.09 63.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . 0.491 ' HB3' ' OG ' ' A' ' 59' ' ' SER . . . -145.8 81.99 1.62 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.849 176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -84.74 162.55 19.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.447 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.41 126.98 31.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.409 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.258 -178.359 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -111.97 104.38 12.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.028 0.442 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -94.29 63.74 3.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.255 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . 74.31 -74.52 1.24 Allowed Glycine 0 N--CA 1.453 -0.197 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -117.61 125.44 50.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.75 -25.44 34.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.402 0.62 . . . . 0.0 110.314 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.63 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 62.1 t -130.59 116.77 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.661 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 26.1 t -127.96 141.01 51.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.599 HD13 ' CH2' ' A' ' 40' ' ' TRP . 38.2 tp -87.95 119.08 27.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 28' ' ' PHE . 9.3 mp -75.43 -34.0 60.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.209 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.99 177.77 38.37 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.539 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.549 HD11 HG21 ' A' ' 109' ' ' VAL . 11.3 mt -133.44 142.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 53.5 tptt -109.0 111.31 22.89 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.059 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 139' ' ' ILE . 78.0 t -69.36 98.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 168.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 10' ' ' LYS . 2.9 mm? -65.34 -25.58 67.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.995 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.01 117.17 29.83 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -167.54 118.43 0.7 Allowed Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.148 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -77.83 173.7 55.87 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.601 -0.999 . . . . 0.0 112.296 -4.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.36 179.52 8.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -94.26 167.36 11.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 132' ' ' VAL . 79.9 t80 -67.19 -33.02 74.51 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.985 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.404 HG23 HG11 ' A' ' 132' ' ' VAL . 1.3 p -89.52 13.89 12.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.707 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -82.48 144.0 48.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 26.1 Cg_endo -63.26 122.1 10.17 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.399 2.066 . . . . 0.0 111.374 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.31 130.79 35.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.571 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 44.9 mt-10 -123.37 119.17 29.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . 90.0 m-85 -125.16 134.94 52.22 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 24.6 tt0 -99.5 116.86 32.6 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.716 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 97' ' ' LEU . 24.5 mm -89.88 126.55 42.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 96.4 m -131.37 116.82 18.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.341 171.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' HA ' HD13 ' A' ' 7' ' ' LEU . 40.9 p90 -138.33 160.39 39.61 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 7' ' ' LEU . 17.3 pt-20 -105.4 126.13 51.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.453 0.644 . . . . 0.0 110.422 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.6 t -99.27 108.22 20.71 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.776 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.35 -23.13 43.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -151.18 136.28 17.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 t -59.37 127.26 31.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 111.019 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD23 HG22 ' A' ' 65' ' ' VAL . 1.7 mm? -84.92 130.94 34.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.014 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HD2' ' OD2' ' A' ' 154' ' ' ASP . 0.0 OUTLIER -80.56 -23.37 39.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.044 172.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 101' ' ' TYR . 13.7 m170 -98.54 169.19 9.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.591 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -100.51 149.93 23.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.073 0.463 . . . . 0.0 111.992 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 62' ' ' VAL . 50.4 mt -98.95 132.6 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.61 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 31.3 tt0 -112.08 113.61 25.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.627 0.251 . . . . 0.0 110.486 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE3' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m95 -103.8 133.82 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -148.23 162.65 39.05 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.191 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 57' ' ' LEU . 2.2 tp -124.19 125.46 44.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.275 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.5 m -110.59 136.68 49.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 21.1 t80 -91.12 113.46 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 53' ' ' HIS . 58.0 t -116.56 145.7 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 123.523 0.515 . . . . 0.0 111.343 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.24 127.45 7.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.151 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.8 m 69.69 -74.43 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 t -158.7 -50.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 110.066 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.27 -100.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 t 171.78 128.05 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 123.555 0.534 . . . . 0.0 111.537 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.8 mt -104.27 -67.43 0.9 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -117.23 23.69 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.812 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 54.1 m-70 -133.25 66.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -169.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 19.2 p-10 -149.4 76.94 1.33 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.518 1.151 . . . . 0.0 109.821 167.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.82 116.99 28.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.595 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.06 122.56 17.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.462 HD23 HD23 ' A' ' 42' ' ' LEU . 2.6 mm? -77.8 -38.68 46.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.877 -175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -176.94 177.43 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -159.4 127.78 5.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.033 0.444 . . . . 0.0 110.587 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' B' ' 426' ' ' PRO . 33.4 pt -117.69 153.15 19.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.058 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 38' ' ' LEU . 3.4 tm? -123.71 136.07 54.24 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -127.55 133.77 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.953 -0.467 . . . . 0.0 111.351 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.23 153.85 6.92 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.719 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.07 127.81 11.8 Favored 'Cis proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.193 -1.586 . . . . 0.0 111.841 -4.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.494 HG22 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -94.64 120.24 65.13 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 -175.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.29 173.46 5.6 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.73 2.953 . . . . 0.0 113.653 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.7 144.66 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.24 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.2 13.99 Favored Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' B' ' 421' ' ' ILE . 0.3 OUTLIER -85.48 139.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 422' ' ' THR . 0.9 OUTLIER -111.04 137.73 48.32 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 21.4 ttmm -140.01 129.59 24.29 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -172.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -164.04 166.15 21.72 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.202 0.525 . . . . 0.0 110.575 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.71 131.02 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.996 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -103.95 101.47 11.25 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.5 p -87.87 113.64 23.72 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.499 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.45 147.06 41.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.048 0.452 . . . . 0.0 111.268 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -96.72 127.68 38.59 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.722 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 21' ' ' PRO . 37.8 Cg_endo -63.93 156.45 58.24 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.336 2.691 . . . . 0.0 112.73 -177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 78' ' ' PRO . 8.4 Cg_endo -84.56 151.03 11.66 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.821 2.348 . . . . 0.0 111.231 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.409 ' OG ' ' HG2' ' A' ' 82' ' ' GLU . 10.5 t -70.9 124.05 23.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 130' ' ' VAL . . . -64.77 -14.87 60.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.447 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG ' ' A' ' 80' ' ' SER . 13.3 pt-20 -57.07 -19.92 21.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 80' ' ' SER . 12.7 mt -79.26 -28.67 42.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 109.903 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 pt -123.07 107.81 32.74 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.988 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.02 161.03 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.325 2.684 . . . . 0.0 112.75 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.34 -47.73 36.82 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.0 m -80.43 -1.32 40.96 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.089 -0.382 . . . . 0.0 111.833 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -98.24 -24.95 15.04 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 89' ' ' LEU . 2.6 pt? -99.55 -15.78 18.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.53 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 116' ' ' GLU . 94.1 t -81.47 65.23 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 122.355 1.074 . . . . 0.0 109.822 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.3 m -148.68 171.03 16.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.835 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 27.7 m -79.78 120.76 31.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.637 0.732 . . . . 0.0 109.421 173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -114.36 178.27 4.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.814 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 61.7 t -126.79 134.94 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.049 0.452 . . . . 0.0 110.56 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 78.2 mt -104.91 134.92 45.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.619 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.9 mt -114.15 114.33 25.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.706 0.289 . . . . 0.0 110.661 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 26' ' ' ILE . 3.5 tt -99.21 115.12 28.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.8 p -135.43 137.07 41.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.381 0.61 . . . . 0.0 111.684 -170.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 38.8 t -115.88 137.76 51.8 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.264 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -120.01 133.76 55.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.251 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 85.5 t80 -110.38 111.57 22.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 62.18 29.81 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.702 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.74 -10.58 70.51 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.862 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 20.7 mtp180 -95.51 115.34 27.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.006 0.403 . . . . 0.0 111.113 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.01 121.04 21.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.394 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 37.4 p90 -110.38 -25.08 10.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.354 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.6 t -136.28 120.0 23.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 0.0 110.433 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -131.95 118.69 20.11 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.727 HG13 HG22 ' A' ' 146' ' ' VAL . 1.8 t -111.2 121.62 64.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 95' ' ' ILE . . . -106.24 145.81 15.99 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.692 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.0 m-85 -138.85 148.62 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HE3' ' A' ' 143' ' ' LYS . 64.4 m-85 -95.12 140.34 30.19 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -124.11 127.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.117 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.87 127.25 34.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.59 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 23.6 m-80 -124.57 124.93 43.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HA ' HG13 ' A' ' 90' ' ' VAL . 13.7 pt-20 -153.14 163.64 39.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 -173.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.619 ' O ' ' HD2' ' A' ' 123' ' ' ARG . 39.9 m-85 -87.15 122.9 31.59 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -16.26 63.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.75 0.31 . . . . 0.0 110.633 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 15.2 mm-40 -96.92 121.89 39.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 0.0 111.183 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 26.9 tt0 -65.37 -30.19 70.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.909 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.38 -38.25 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.77 0.319 . . . . 0.0 111.106 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.98 -20.56 30.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.453 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 117' ' ' TYR . 50.0 mtp85 -74.95 -41.07 60.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.623 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 8.0 mm-40 -77.73 -39.36 44.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.941 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -123.59 90.24 50.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.102 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.07 124.93 10.45 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.823 2.349 . . . . 0.0 112.525 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.24 169.57 12.61 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.555 2.17 . . . . 0.0 111.707 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.19 -49.43 11.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -77.84 137.23 38.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.308 0.575 . . . . 0.0 110.94 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG11 ' HB1' ' A' ' 81' ' ' ALA . 7.5 p -79.08 137.42 21.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.436 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.75 78.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.667 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 2.9 t -64.76 -19.74 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.454 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.27 -16.81 37.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.952 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -122.05 17.84 10.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.449 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 130' ' ' VAL . 61.5 mt -98.75 127.88 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 109.79 174.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 53.9 t -97.92 129.89 47.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.586 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -107.33 112.78 25.78 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -110.59 112.44 24.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.141 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 11' ' ' VAL . 7.0 mt -83.79 118.49 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.78 74.56 6.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.243 0.544 . . . . 0.0 109.977 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.02 -9.41 58.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.454 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 143' ' ' LYS . 8.5 pt-20 -58.76 -26.44 64.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.833 174.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 112' ' ' TYR . 30.6 pttt -128.72 94.04 35.92 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-O 121.265 0.555 . . . . 0.0 110.842 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -83.74 125.94 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.577 2.851 . . . . 0.0 111.464 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -104.43 105.45 15.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.727 HG22 HG13 ' A' ' 109' ' ' VAL . 10.7 t -107.27 131.85 56.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 108' ' ' ARG . 23.8 m -129.3 125.76 37.49 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 1.2 mpp_? -113.92 132.19 56.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.965 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.91 139.15 41.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -78.7 102.34 8.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.212 0.529 . . . . 0.0 110.364 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 106' ' ' PHE . 12.8 pt -117.19 170.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.45 123.47 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 90.0 m95 -100.39 134.46 43.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -169.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 21.7 t70 57.86 -57.99 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 125.345 1.653 . . . . 0.0 113.595 175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 153' ' ' TRP . 31.1 m-80 -96.21 46.49 1.07 Allowed 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 122.942 0.497 . . . . 0.0 110.944 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 104' ' ' ARG . 42.0 tt0 -78.05 96.6 5.15 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.525 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 33.7 t30 70.22 134.89 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 122.127 0.965 . . . . 0.0 112.602 171.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.87 69.48 0.71 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -83.3 55.34 5.03 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.647 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.17 73.12 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.093 0.473 . . . . 0.0 110.034 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.65 10.08 1.93 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.941 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -118.43 93.34 45.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 51.7 Cg_exo -55.97 135.88 71.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.092 2.528 . . . . 0.0 112.455 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 163' ' ' PRO . 59.9 Cg_endo -88.43 85.49 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.659 2.24 . . . . 0.0 111.801 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.72 106.72 11.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.265 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -76.56 119.54 77.8 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.58 65.59 8.62 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.701 2.267 . . . . 0.0 112.391 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.99 46.8 3.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.115 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.165 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' LEU . . . . . . . . . . . . . 65.0 tp . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.784 0.326 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' ALA . . . . . 0.423 ' C ' HG13 ' B' ' 421' ' ' ILE . . . -87.64 134.51 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.33 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' ILE . . . . . 0.585 HG22 ' H ' ' B' ' 422' ' ' THR . 0.9 OUTLIER 57.0 -179.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.936 -176.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . 0.585 ' H ' HG22 ' B' ' 421' ' ' ILE . 28.4 m -138.97 104.04 4.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.816 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' MET . . . . . . . . . . . . . 17.4 mmt -83.69 79.48 9.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.783 0.801 . . . . 0.0 109.445 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.483 HD12 HG12 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.13 -39.25 94.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.894 -174.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 61.26 88.84 0.11 Allowed Pre-proline 0 C--O 1.233 0.219 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' PRO . . . . . 0.531 ' HB3' HG13 ' A' ' 62' ' ' VAL . 72.6 Cg_endo -71.95 104.61 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.804 2.336 . . . . 0.0 112.704 -171.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -63.75 135.0 56.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -70.61 172.21 9.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -76.05 53.41 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.582 0.706 . . . . 0.0 112.146 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.54 31.72 5.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -78.7 -26.34 44.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.828 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . -81.5 62.53 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.641 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.766 -179.179 . . . . . . . . 0 0 . 1 stop_ save_